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leABSTRACT:  Background: Ethanol (ETOH) exposure during pregnancy is associated with 
craniofacial and neurologic abnormalities, but infrequently disrupts the anterior segment 
of the eye. In these studies, we used zebrafish to investigate differences in the 
teratogenic effect of ETOH on craniofacial, periocular, and ocular neural crest. 
Methods: Zebrafish eye and neural crest development was analyzed via live imaging, 
TUNEL assay, immunostaining, detection of reactive oxygen species, and in situ 
hybridization. 
Results: Our studies demonstrated that foxd3-positive neural crest cells in the 
periocular mesenchyme and developing eye were less sensitive to ETOH than sox10-
positive craniofacial neural crest cells that form the pharyngeal arches and jaw. ETOH 
increased apoptosis in the retina, but did not affect survival of periocular and ocular 
neural crest cells. ETOH also did not increase reactive oxygen species within the eye. 
In contrast, ETOH increased ventral neural crest apoptosis and reactive oxygen species 
production in the facial mesenchyme. In the eye and craniofacial region, sod2 showed 
high levels of expression in the anterior segment and in the setting of  and Sod2 
knockdown, low levels of ETOH decreased migration of foxd3-positive neural crest cells 
into the developing eye. was specifically upregulated by ETOH compared to sod1 and 
sod3, which were expressed in the retina and facial mesenchyme. HoweverFurther, 
ETOH had minimal effect on the periocular and ocular expression of transcription 
factors (pitx2 and foxc1) that regulate anterior segment development.  
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leConclusions: Neural crest cells contributing to the anterior segment of the eye exhibit increased ability to withstand ETOH-induced oxidative stress and apoptosis. These 
studies explain the rarity of anterior segment dysgenesis despite the frequent 
craniofacial abnormalities in fetal alcohol syndrome. 
Keywords: Neural crest, fetal alcohol syndrome, eye development, anterior segment, 
superoxide dismutase, ethanol, congenital eye disease  
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leINTRODUCTION  Fetal alcohol spectrum disorders refer to the range of multi-systemic anomalies 
resulting from alcohol consumption during pregnancy (Hoyme et al., 2005;Jones et al., 
1973;Lemoine et al., 2003;Riley et al., 2011;Sokol, 2003). The most severe 
manifestation in this spectrum is referred to as fetal alcohol syndrome (FAS) and 
includes a combination of growth retardation, neurological deficits, and craniofacial 
malformations. The neuroepithelium, which forms the central nervous system, and the 
cranial neural crest, which gives rise to the bone and connective tissue of the 
craniofacial region, are tissues that are highly sensitive to the effects of ethanol 
(ETOH)(Clarren et al., 1978;Kiecker, 2016;Lovely et al., 2016;Mattson and Riley, 
1996;Sampson et al., 1997). In humans and animals, the effects of ETOH on brain and 
cranial neural crest development are closely related to the duration and concentration of 
exposure (Joya et al., 2014;Kiecker, 2016;Riley et al., 2011;Sulik et al., 1981;Zhang et 
al., 2014). Numerous studies have demonstrated that ETOH alters the patterning of the 
neuroepithelium resulting in the inhibition of neuronal induction, proliferation and 
survival (Dunty et al., 2002;Maier et al., 1997;Maier et al., 1999;Parnell et al., 2009;Sulik 
et al., 1984;Zhang et al., 2016). These alterations commonly disrupt neurological 
function and behavior, and in severe cases, leads to structural abnormalities, such as 
agenesis of the corpus callosum and cerebellar hypoplasia (Hoyme et al., 
2005;Lemoine et al., 2003;Mattson and Riley, 1996;Riley et al., 2011;Sokol, 2003). In 
the adjacent neural crest, early exposure to ETOH decreases delamination, inhibits 
proliferation, decreases survival, and alters migration (Flentke et al., 2011;Garic et al., 
2011;Garic-Stankovic et al., 2005;Smith et al., 2014;Tolosa et al., 2016), resulting in the 
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leclassic craniofacial anomalies associated with FAS (e.g. thin vermillion, shortened palpebral fissures, and smooth philtrum), and also causinges cleft lip and cleft palate in 
severe cases (Foroud et al., 2012;Hoyme et al., 2005;Klingenberg et al., 2010;Riley et 
al., 2011).  
The cranial neural crest, which arises from the prosencephalon, mesencephalon, 
and rhombencephalon, follows specific migratory pathways into the craniofacial region 
(Bohnsack and Kahana, 2013;Chawla et al., 2016;Trainor, 2005;Trainor and Tam, 
1995). At the same time that the jaw and pharyngeal arches are forming, a subgroup of 
neural crest cells, which initially populates the periocular mesenchyme, enters the eye 
(Creuzet et al., 2005;Johnston, 1966;Johnston et al., 1979). In other congenital 
disorders (e.g. Axenfeld-Rieger Syndrome and Peters Plus Syndrome), craniofacial 
anomalies are associated with malformations of the anterior segment of the eye (Aliferis 
et al., 2010;Dressler et al., 2010;Lesnik Oberstein et al., 2006;Ozeki et al., 
1999;Schoner et al., 2013;Strungaru et al., 2007;Tumer and Bach-Holm, 2009). 
Interestingly, corneal, iris, and angle abnormalities are a rare manifestation of FAS 
(Brennan and Giles, 2014;Chan et al., 1991;Edward et al., 1993;Miller et al., 
1984;Stromland, 1987). The molecular differences between neural crest cells that give 
rise to craniofacial structures versus neural crest cells that form the anterior segment 
are not well defined. Differences in sensitivity to ETOH suggest that the periocular and 
ocular neural crest are molecularly distinct from the craniofacial neural crest. Although 
numerous studies have investigated the effect of ETOH on the cranial neural crest in 
facial development, few studies have focused on the periocular and ocular populations. 
Page 5 of 109
John Wiley & Sons, Inc.
Birth Defects Research Part A: Clinical and Molecular Teratology
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
leIn the present study, we used a zebrafish model of FAS to investigate the effects of ETOH exposure on the periocular and ocular neural crest. The neural crest cells that 
enter the eye have been difficult to study, reflecting their transient nature and the lack of 
adequate markers to track this migrating population. We identified foxd3 as a marker for 
these cells within zebrafish embryos and larvae in contrast to sox10, which was 
predominantly detected in craniofacial neural crest cells. Using these 2 markers, we 
investigated diffe ences in cell survival, reactive oxygen species (ROS) production and 
gene expression in response to ETOH exposure in these neural crest cell populations.  
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leMATERIALS AND METHODS: Animal Care/Animal Strains 
Zebrafish (Danio rerio) were raised in a breeding colony under a 14-h light/10-h 
dark cycle as previously described (Bohnsack et al., 2011a;Bohnsack et al., 
2011b;Bohnsack and Kahana, 2013;Bohnsack et al., 2012;Chawla et al., 2016). 
Embryos were maintained at 28.5 degrees Celsius and staged as previously described 
(Kimmel et al., 1995). The transgenic strains Tg(sox10:EGFP), Tg(sox10:mRFP), and 
Tg(foxd3:GFP) were gifts from Thomas Schilling, Cunming Duan, and Mary Halloran, 
respectively, and the strains were crossed into the Roy (roy -/-) or Casper (roy -/-, nacre 
-/-) background to decrease auto-fluorescence and interference resulting from 
pigmentation (Curran et al., 2009;Dutton et al., 2001a;Dutton et al., 2001c;Kucenas et 
al., 2008). Animal protocols were performed in accordance with the guidelines for the 
humane treatment of laboratory animals established by the University of Michigan 
Committee on the Use and Care of Animals (IACUC, protocol #10205) and the ARVO 
(Association for Research in Vision and Ophthalmology) Statement for the Use of 
Animals in Ophthalmic and Vision Research.  
 
Pharmacological treatments 
Absolute ethanol (ETOH, Sigma-Aldrich, St. Louis, MO, USA) was administered in the 
embryo media at 0.5-3%. The embryos were dechorionated, and the treatments were 
administered from 24 to 48 hours post fertilization (hpf). Following treatment, the 
embryos were washed multiple times with embryo media and subsequently placed in 
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lefresh embryo media for the remainder of the time course as indicated. Experiments utilized 50-100 embryos per treatment group and were replicated 4-6 times. Phenotypes 
were assessed at 72 hpf, and the data were statistically analyzed using ANOVA with 
Tukey’s post-hoc analysis. A p value of <0.5 was considered statistically significant. 
(Peterman et al., 2015) 
 
Imaging 
Whole embryos were analyzed using a M205FA combi-scope (Leica 
Microsystems CMS GmbH, Germany, Wetzler, Germany). Images were obtained using 
brightfield DFC290 (Leica) and fluorescent ORCA-ER (Hamamatsu, Hamamatsu City, 
Japan) cameras. The sections were imaged using a DM6000B upright microscope 
(Leica) equipped with a DFC500 camera (Leica). The images were processed and 
analyzed using Adobe Photoshop (San Jose, CA, USA), LAS software X  (Leica) and/or 
LAS AF6000 software (Leica). The images shown are representative of all experiments. 
For quantifying the number of foxd3-positive periocular mesenchymal and ocular neural 
crest cells, z-stacks that ranged from the lateral edge of the cornea to 100 µm medial to 
the medial edge of the eye were obtained. The z-stacks were deconvolved and 
maximally projected in order to obtain a single image. The number of foxd3-positive 
cells was manually counted. The images shown are representative of all experiments. 
Eye size was measured from the dorsal to ventral border in a lateral view and from the 
anterior to posterior border in a ventral view. Measurements were obtained from the 
bilateral eyes of 45-6 embryos at each time point for each group. The data were 
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lestatistically analyzed using ANOVA with Tukey’s post-hoc analysis, and p<0.05 was considered statistically significant. 
 
Pharmacological treatments 
Absolute ethanol (ETOH, Sigma-Aldrich, St. Louis, MO, USA) was administered 
in the embryo media at 0.5-3%. The embryos were dechorionated, and the treatments 
were administered from 24 to 48 hours post fertilization (hpf). Following treatment, the 
embryos were washed multiple times with embryo media and subsequently placed in 
fresh embryo media for the remainder of the time course as indicated. Experiments 
utilized 50-100 embryos per treatment group and were replicated 4-6 times. Phenotypes 
were assessed at 36, 48, 60, and 72 hpf. Data were statistically analyzed using ANOVA 
with Tukey’s post-hoc analysis. A p value of <0.5 was considered statistically significant.  
 
Morpholino Oligonucleotide Injections 
Translation blocking (GAACATATCCGACTCTGCACAGCAT) and 5-basepair 
mismatch control (GAAGAAATCGGACTCTCCACACCAT) antisense morpholino 
oligonucleotides (MO; Gene Tools, LLC Cowallis, OR) directed against zebrafish Sod2 
were reconstituted in de-ionized water. The sequences for the MO were previously 
published (Peterman et al., 2015). Concentrations yielding consistent and reproducible 
phenotypes were determined for each MO. One-cell stage embryos were injected with 
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le1-2 nL of MO at a concentration of 0.25 mM (2.1ng/nl). Embryos were imaged at 24, 36, 48, and 60 hpf as described above.  
 
Methylacrylate sections 
Zebrafish embryos at 96 hpf were fixed in 2% paraformaldehyde/1.5% 
glutaraldehyde overnight at 4 degrees Celsius, followed by embedding in 
methylacrylate. The blocks were sectioned at 5 µm. The sections were stained with 
Lee’s stain and imaged as described above.  
 
Immunostaining and TUNEL assay 
The staged zebrafish embryos were fixed in 4% paraformaldehyde overnight at 4 
degrees Celsius. Wholemount immunostaining for green fluorescent protein (GFP) and 
terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays were 
performed as previously described using standard protocols (Bohnsack and Kahana, 
2013). Briefly, apoptotic cells were detected through the TdT-mediated incorporation of 
digoxigenin-labeled deoxyuridine triphosphate. Sheep anti-digoxigenin conjugated to 
rhodamine was used to detect the TUNEL signal. The embryos were subsequently 
incubated with mouse anti-green fluorescent protein (GFPGFP) directly conjugated to 
FITC (1:200, Millipore, Billerica, MA, USA). The embryos were cryoprotected in 
successive sucrose solutions, embedded in Optimal Cutting Temperature (O.C.T) 
compound, and subsequently sectioned at 10 µm. The sections were co-stained with 
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leDAPI and imaged as described above. For quantification of the percentage of cells undergoing apoptosis in the eye at 48 hpf, 3 consecutive sections through the equator 
of the lenses of at least 4 embryos per group were included. The number ofTotal cell 
nuclei as marked by DAPI staining and the number of TUNEL-positive cells in the eyes 
were manually counted. The data were statistically analyzed using ANOVA with Tukey’s 
post hoc analysis, and p<0.05 was considered statistically significant. 
For Sod2 immunostaining, embryos were harvested at 48 hpf, fixed in 4% 
paraformaldehyde and cryoprotected in successive sucrose solutions. Embryos were 
embedded in O. C. T compound and sectioned at 10 µm. The sections were washed in 
PBS, dehydrated in acetone, and blocked in 10% normal goat serum in PBS with 0.1% 
triton. Sections were incubated with anti-Sod2 (1:100, Genetex, Irvine, CA, USA) 
overnight at 4 degrees Celsius. The sections were washed in PBS and then incubated 
with goat anti-rabbit secondary antibody conjugated to Cy3 (1:1000, Abcam, 
Cambridge, MA, USA) for 2 hours at room temperature. The sections were washed, 
costained with DAPI, and imaged as described above.  
 
Detection of Reactive Oxygen Species (ROS) 
 Tg(sox10:mRFP) embryos were incubated with CellROX Green Reagent 
(Molecular Probes, Life Technologies, Carlsbad, CA, USA) at a final concentration of 5 
µM in embryo media for 30 min in the dark prior to harvesting in 4% paraformaldehyde 
at 26 hpf.(Mugoni et al., 2014) The embryos were cryoprotected in successive sucrose 
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lesolutions, embedded in O.C.T., and sectioned at 10 µm. The sections were immediately co-stained with DAPI and imaged as described above.  
 
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) 
 Total mRNA from 48 hpf embryos was isolated using the ReliaPrep RNA Tissue 
Miniprep System (Promega, Madison, WI, USA) and quantified using Nanodrop 2000 
(Thermo Scientific, Willmington, DE, USA) spectrophotometry. One microgram of RNA 
was reverse transcribed using Superscript IV Reverse Transcriptase (ThermoFisher 
Scientific, Waltham, MA, USA). The primer sequences for sod1, sod2, sod3, pitx2a, 
foxc1a, foxc1b, and β−actin are listed in Supplemental Table 1. For semi-quantitative 
RT-PCR, cycle optimization was performed to determine the linear range of each primer 
set (Supplemental Table 1). PCR was performed using Platinum Taq (ThermoFisher), 
and the products were detected on 2% agarose gels. Each experiment was repeated 4 
times, and the images shown are representative of all experiments.  
 
 
In situ hybridization 
In situ hybridization was performed through standard protocols using digoxigenin- 
labeled RNA antisense probes (Barthel and Raymond, 2000;Bohnsack et al., 2011b). 
For colorimetric reactions and signal comparisons, the embryos were developed for 
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leequal amounts of time. Sense controls were also developed in parallel to ensure specific staining.  
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leRESULTS Migration of craniofacial and periocular neural crest showed different sensitivities 
to ETOH.  
Traceable differences between the cranial neural crest cells that give rise to the 
craniofacial structures versus those that contribute to the anterior segment of the eye 
were determined using the Tg(sox10:mRFP), Tg(foxd3:GFP) and Tg(sox10:mRFP; 
foxd3:GFP) transgenic lines. The transcription factors sox10 and foxd3 have been 
shown in numerous animal models to regulate early neural crest differentiation and are 
markers for neural crest cells (Dutton et al., 2001b;Honoré et al., 2003;Kwak et al., 
2013;Montero-Balaguer et al., 2006;Stewart et al., 2006). In the present study, we 
observed that sox10 and foxd3 predominantly demarcated separate neural crest cell 
populations in the periocular mesenchyme and within the eye (Fig. 1 A’’-D’’). Only a 
small proportion of neural crest cells entering the eye were sox10-positive (Fig. 1A-D). 
These sox10-positive cells migrated between the optic cup and surface ectoderm, 
peaking at approximately 36 hpf. Sox10 was no longer detected in the anterior segment 
after 60 hpf (Fig. 1D, 1D’’, and 1F), but maintained expression in the jaw and 
pharyngeal arches at 96 hpf (Fig. 1E, F). As previously demonstrated, foxd3 marked a 
higher proportion of neural crest cells that entered the eye (Fig. 1A’-D’) (Williams et al., 
2017). Foxd3-positive cells migrated between the optic cup and surface ectoderm and 
through the ocular fissure (arrow, Fig. 1B’, 1C’, 1B’’ and 1C’’) and through the ocular 
fissure (arrow). Foxd3-positive cells coalesced around the lens and contributed to the 
iris stroma (closed arrow, Fig. 1E, 1F’), corneal stroma (Fig. 1F’, open arrow), and 
aqueous outflow channels (Fig. 1F’, arrowhead) at 96 hpf. Foxd3 was not expressed in 
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lethe jaw or pharyngeal arches at 96 hpf (Fig. 1E’). Foxd3 was also detected in differentiated photoreceptors (Fig. 1E’ and 1F’, open arrowhead), but this expression 
was not related to neural crest cells. Thus, sox10 and foxd3 demarcated different neural 
crest cell populations that give rise to the jaw/pharyngeal arches and anterior segment 
structures, respectively. 
To determine the effect of ETOH on anterior segment formation, Tg(foxd3:GFP) 
embryos were treated with increasing concentrations of ETOH (0.5%, 1% and 3%) 
between 24 and 48 hpf and subsequently live imaged. This time window frame occurs 
after early neural crest migration into the craniofacial region and optic cup formation and 
during neural crest migration into the anterior segment of the eye. Treatment with 0.5% 
or 1% ETOH between 24 and 48 hpf did not decrease embryo survival at 72 hpf 
compared to untreated embryos (Fig. 2A) or significantly affect eye size (Fig. 2B, 
Supplemental Table 2) as measured along the anterior-posterior and dorsal-ventral and 
anterior-posterior axes. In the eye, 0.5% (data not shown) or 1% ETOH (Fig. 3B’-3E’G-
3I) did not decrease foxd3-positive cells in the periocular mesenchyme (arrowheads) or 
alter ocular neural crest migration (closed arrows) between 24 and 7260 hpf compared 
to untreated controls (Fig. 3A-ED). Further, 1% ETOH did not affect photoreceptor 
expression of foxd3 at 72 hpf (open arrows, Fig. 1E’). At 96 hpf, methylacrylate sections 
showed that 1% ETOH did not affect iris stroma formation (arrowheads, Fig. 3F’J) 
compared to untreated embryos (Fig. 3FE). In contrast, treatment of Tg(sox10:EGFP) 
embryos with 1% ETOH from 24 to 48 hpf (Fig. 3G’K) showed delayed development of 
the pharyngeal arches (PA), ceratohyal (CH) cartilage, and Meckel’s (Mk) cartilage at 
96 hpf compared to untreated controls (Fig. 3FG).  
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leTreatment with 3% ETOH from 24 to 48 hpf significantly decreased eye size in both the dorsal-ventral and anterior-posterior axes (Fig. 2B, Supplemental Table 2). 
However, 3% ETOH from 24 to 48 hpf did not significantly decrease embryo survival at 
72 hpf (p=0.81). In Tg(foxd3:GFP) embryos tThis higher concentration of ETOH 
significantly did not affect the foxd3-positive cells in the periocular 
mesenchymedecreased the number of foxd3-positive neural crest cells in the periocular 
mesenchyme (ar owheads) and in the developing eye (arrows) at 48 hpf compared to 
untreated and 1% ETOH treated embryos (Supplemental Table 3, Fig. 3B’’-E’’, 3H,). 
(arrowhead, Fig. 3L-3N). Further, However, there were tfoxd3-positive cells that hese 
cells migratedd into the anterior segment (arrow) of the eye frombetween 24 to 36 and 
7260 hpf. Although the eyes were smaller with misshapen lenses, the neural crest cells 
formed iris stroma (arrowheads, Fig. 3F’’O) and corneal stroma (arrow) at 96 hpf. 
Treatment of Tg(sox10:EGFP) embryos with 3% ETOH resulted in severe malformation 
of pharyngeal arch, ceratohyal, and Meckel’s cartilage at 96 hpf (Fig. 3G””P). Thus, 
periocular and ocular neural crest cells are less sensitive to ETOH compared to the 
neural crest cell population that gives rise to the craniofacial cartilages.  
 
Ethanol induced apoptosis in the periocular mesenchyme and the eyeretina, lens, 
and facial mesenchyme. 
 Previous studies have shown that ETOH increases craniofacial neural crest 
apoptosis, but the effects of ETOH on the survival of the neural crest inside and around 
the eye have not been determined (Garic-Stankovic et al., 2005;Smith et al., 2014). 
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leTUNEL assay in Tg(sox10:EGFP) and Tg(foxd3:GFP) embryos demonstrated that 1% ETOH starting at 24 hpf significantly increased the percentage of apoptotic cells in the 
developing eye at 30 (Fig. 4C’ and 4D’) and 33 (Fig. 4E’ and 4F’, Fig. 5, Supplemental 
Table 43) hpf compared to untreated controls (Fig. 4C, 4D, 4E, and -4F). The apoptotic 
cells in the eyes were not specifically localized to sox10 or foxd3-positive neural crest 
cells in the periocular mesenchyme or the eye. Treatment with 1% ETOH did not affect 
cell survival at 27 (Fig. 4A’ and 4B’), 36 (Fig. 4G’ and 4H’) and 48 (Fig. 4I’ and 4J’) hpf 
compared to untreated controls (Fig. 4E-, 4F, 4G, 4H, 4I, and 4J). Between 30 and 48 
hpf, apoptotic cells were also observed in the jaw mesenchyme (arrowheads, Fig. 4F’, 
4H’ and 4I’, arrowheads). Treatment with 3% ETOH starting at 24 hpf significantly 
increased the percentage of apoptotic cells in the developing eye from 30 to 48 hpf (Fig. 
4C’’-4J’’, Fig. 5, Supplemental Table 43). In 3% ETOH-treated embryos, the cells 
undergoing apoptosis were located throughout the eye, particularly in the retina and 
lens (Fig. 4C’’ and 4D’’). These findings show that ETOH induced apoptosis in the 
neural crest in the facial mesenchyme, but spared the neural crest in the anterior 
segment of the eye.  
 
Ethanol increased oxidative stress in the facial mesenchyme, but not the ocular 
neural crest.   
 Ethanol-induced apoptosis in the cranial neural crest and neuroepithelium has 
previously been attributed in part to an increase in ROS oxidative stress (Chen et al., 
2000;Davis et al., 1990;Floyd and Carney, 1992;Henderson et al., 1995). Using Tg 
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le(sox10:mRFP) embryos, we investigated whether ETOH exposure also increased oxidative stressROS in and around the eye. Within 2 hours of ETOH exposure (1% or 
3%), increased ROS was observed in the sox10-positive ventral neural crest cells, 
which forms the facial mesenchyme (arrows, Fig. 6B and 6C, arrows), compared to 
untreated controls (Fig. 6A). However, there was no increased ROS within the 
developing eye. 
 Superoxide dismutase enzymes, namely sod1, sod2, and sod3, are important 
antioxidant molecules that catalyze the conversion of ROS to less harmful byproducts 
(Kajimura et al., 2005;Koch et al., 1994;Koch et al., 1991;Koch et al., 2004). To further 
investigate the To investigate the resistance of periocular and ocular neural crest cells 
to oxidative stress-induced by ETOH, the expression of the sod genes in and around 
the developing eye was next determined, the expression of the sod genes was 
determined. In situ hybridization at 36 hpf showed that all of the sod enzymes were 
expressed within the hyaloid vasculature (arrowhead, Fig. 6DE-6FG) and periocular 
mesenchyme. Sod1 and sod3 were also expressed within the retina and facial 
mesenchyme (open arrow), while sod2 was the predominant enzyme in the anterior 
segment. Sod2 was expressed in lens epithelial cells and the neural crest cells between 
the optic cup and surface ectoderm (arrows, Fig. 6EE’, arrows). Semi-quantitative Thus, 
the developing eye shows the regional expression of sod enzymes that were 
differentially regulated by ETOH exposure.  
RT-PCR of RNA from whole 48 hpf embryos revealed that treatment with 1% or 3% 
ETOH starting at 24 hpf decreased the overall transcript expression of sod1 and sod3 at 
48 hpf compared to untreated controls (Fig. 6GD). Notably, 1% ETOH increased sod2 
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leexpression at 48 hpf, whereas treatment with 3% ETOH decreased sod2 expression. Immunohistochemistry confirmed protein expression of Sod2 within the anterior 
segment (arrows, Fig. 6H) and further showed that protein levels were increased by 1% 
ETOH (Fig. 6H’), but decreased by 3% ETOH exposure (Fig. 6H’’). Thus, the 
developing eye has regional expression of sod enzymes that are differentially regulated 
by ETOH exposure.  
 Since Sod2 was expressed in the anterior segment, the effect of this enzyme on 
the ocular neural crest was determined. Knockdown of Sod2 (using MO injected into 1-
cell stage Tg(foxd3:GFP) embryos) did not affect foxd3-positive cell migration into the 
anterior segment between 36 and 72 hpf (closed arrows, Fig. 7E-7H) compared to 
mismatch control-injected (Fig. 7A-7D) and uninjected (Fig. 3B-3E) embryos. 
Immunohistochemistry (Fig. 6I) confirmed that MO injection decreased Sod2 protein 
expression at 48 hpf in whole embryos and within the anterior segment. In the setting of 
Sod2 MO knockdown, treatment with 1% ETOH from 24 to 48 hpf decreased foxd3-
positive neural crest cell migration into the anterior segment (arrows, Fig. 7E’-7H’). 
However, there were still foxd3-positive cells in the periocular mesenchyme 
(arrowheads). This was in contrast to mismatch control-injected (Fig. 7A’-7D’) or 
uninjected (Fig. 3B’-3E’) embryos in which 1% ETOH did not affect foxd3-positive cell 
migration into the anterior segment. Treatment with 3% ETOH between 24 and 48 hpf 
decreased foxd3-positive cells in the periocular mesenchyme (arrowheads) and in the 
developing eye in Sod2 knockdown (Fig. 7E’’-7H’’), mismatch control-injected (Fig. 7A’’-
D’’), and uninjected (Fig. 3B’’-3E’’) embryos. These results show that Sod2 provides a 
protective effect against low levels of ETOH exposure in the developing eye.  
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leIn situ hybridization at 36 hpf showed that all of the sod enzymes were expressed within the hyaloid vasculature (arrowhead, Fig. 6E-6G) and periocular mesenchyme. Sod1 and 
sod3 were also expressed within the retina and facial mesenchyme (open arrow), while 
sod2 was the predominant enzyme in the anterior segment. Sod2 was expressed in 
lens epithelial cells and the neural crest cells between the optic cup and surface 
ectoderm (Fig. 6E’, arrows). Thus, the developing eye shows the regional expression of 
sod enzymes that were differentially regulated by ETOH exposure.  
 
Ethanol had a minimal effect on the expression of periocular and ocular genes 
associated with congenital eye diseases.  
 Malformations of the cornea, iris, and angle structures are associated with 
mutations in PITX2 and FOXC1 (Ozeki et al., 1999;Strungaru et al., 2007;Tumer and 
Bach-Holm, 2009). Thus, we next investigated the effect of ETOH exposure on the 
expression of these genes in the periocular mesenchyme and developing eye. Although 
pitx2 has multiple isoforms in zebrafish, we previously demonstrated that pitx2a is the 
predominant form responsible for eye development (Bohnsack et al., 2012). There are 2 
isoforms of foxc1 in zebrafish, foxc1a and foxc1b (Skarie and Link, 2009). Semi-
quantitative RT-PCR showed that 1% or 3% ETOH did not affect the overall expression 
of pitx2a or foxc1a in RNA isolated from whole 48 hpf embryos (Fig. 7A). In situ 
hybridization, which was used to assess expression pattern in the craniofacial region, 
showed that Treatment with 1% or 3% ETOH starting at 24 hpf did not significantly alter 
pitx2a expression in the pituitary (open yellow arrow, Fig. 7B, 7B’, 7B’’) or in the ocular 
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lefissure , periocular mesenchyme (closed arrow, Fig. 7B, 7B’, and 7B’’), and the heart (arrowheadopen arrow, Fig. 7B, 7B’, and 7B’’) in 36 hpf embryos. In addition, ETOH did 
not significantly  affect the expression pattern of foxc1a (Fig. 7A), which was observed 
in the periocular mesenchyme (yellow arrow, Fig. 7C, 7C’, and 7C’’) , facial 
mesenchyme (arrowhead), and the hyaloid vasculaturewithin in the ocular fissure 
(arrowopen arrow, Fig. 7C, 7C’, and 7C’’). However, treatment with 3% ETOH inhibited 
decreased the overall expression of foxc1b in 48 hpf embryos (Fig. 7A), including in the 
periocular mesenchyme (open arrow, (Fig. 7D, D’, and D’’) and facial mesenchyme , 
which was localized to the periocular mesenchyme (arrows) and facial mesenchyme 
(arrowheadsclosed arrows, Fig. 7D, D’, and D’’), but was not observed in the developing 
eye.). These findings show that ETOH affected foxc1b, but not foxc1a or pitx2a in the 
periocular mesenchyme and developing eye. had a minimal effect on the expression of 
genes associated with congenital anterior segment anomalies.  
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leDISCUSSION FAS disorders reflect the disruption of developmental events as a result of 
prenatal alcohol exposure. The major findings and diagnostic criteria include prenatal 
and postnatal growth delay, craniofacial anomalies, and central nervous system 
manifestations (Hoyme et al., 2005;Lemoine et al., 2003;Riley et al., 2011;Sokol, 2003). 
The eyes and visual system, as an extension of the central nervous system, are often 
affected (Brennan and Giles, 2014;Chan et al., 1991;Gummel and Ygge, 2013;Ribeiro 
et al., 2007;Stromland, 1987;Stromland and Pinazo-Duran, 2002;Stromland et al., 
2015). The most common intraocular finding is optic nerve hypoplasia, which affects up 
to 50% of children with FAS and can result in significant visual impairment 
(Abdelrahman and Conn, 2009;Brennan and Giles, 2014;Gummel and Ygge, 
2013;Ribeiro et al., 2007;Stromland and Pinazo-Duran, 2002;Stromland et al., 2015). 
Microphthalmia (small disorganized globe) is also listed as part of the diagnostic criteria 
for FAS (Rossett, 1980), however the prevalence of this condition is more rare (0-5%) of 
in children with FAS) (Abdelrahman and Conn, 2009;Brennan and Giles, 2014;Gummel 
and Ygge, 2013;Ribeiro et al., 2007;Stromland and Pinazo-Duran, 2002;Stromland et 
al., 2015). Both optic nerve hypoplasia and microphthalmia reflect disruptions in 
neuroepithelial-derived optic vesicle formation. Although the neural crest, which gives 
rise to the cornea, iris, sclera, and angle structures, can be disrupted in the context of 
microphthalmia, only 9 cases of isolated anterior segment anomalies in the setting of 
FAS have been reported (Edward et al., 1993;Miller et al., 1984). In contrast, genetic 
causes of congenital anomalies often affect both craniofacial structures and anterior 
segment development (Aliferis et al., 2010;Dressler et al., 2010;Ozeki et al., 1999). 
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leHence, although craniofacial abnormalities are commonly observed in FAS, the development of the anterior segment of the eye is rarely affected, indicating that ocular 
neural crest cells are less sensitive to the effects of ETOH than their craniofacial 
counterparts. 
Cellular and molecular differences between the cranial neural crest cells that give 
rise to craniofacial structures versus those that generate anterior segment structures 
have not been well defined. Although the molecular characteristics and migratory 
pathways of the neural crest cells that give rise to the frontonasal process, Meckel’s 
cartilage, ceratohyal cartilage and pharyngeal arches have been well studied, less is 
known about the cells destined for the anterior segment of the eye. Both of these cell 
populations originate from the edge of the neural tube and migrate into the craniofacial 
region (Dougherty et al., 2012;Trainor, 2005). Our previous studies have shown that 
cells destined for the anterior segment migrate dorsal and ventral to the eye and 
populate the periocular mesenchyme (Bohnsack and Kahana, 2013;Chawla et al., 
2016). However, specific markers for the cells that enter into the eye have not been 
previously identified. In the present study, we observed that sox10 expression was 
decreased in the periocular mesenchyme, and few sox10-positive cells entered the eye 
between the surface ectoderm and optic cup. Further, foxd3 marked a large population 
of cells entering the anterior segment. Although the majority of these cells migrated into 
the dorsal-posterior quadrant between the surface ectoderm and optic cup, foxd3-
positive cells also migrated through the ocular fissure, entering into the anterior 
segment. Studies in mice, chickens, and humans have not demonstrated this alternative 
pathway, however, these studies did not utilize time-lapse live imaging of this migratory 
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lecell population. In zebrafish, similar to mice, we did not observe distinct waves of neural crest cells as previously described in humans and chickens (Hay and Revel, 
1969;O'Rahilly, 1966;1975;Pei and Rhodin, 1970). Classic anatomy studies have 
described 3 waves of neural crest cells in humans and 2 waves in chickens. In humans, 
the first wave contributes to the cornea, the second wave gives rise to the iris, and the 
third wave forms the angle structures. While fate mapping has confirmed that these 
anterior segment structures are derived from the neural crest in chickens and mice, 
similar studies have not been conducted in zebrafish (Gage et al., 2005;Johnston et al., 
1979;Noden, 1983). In the present study, we observed foxd3-positive cells in the iris 
stroma, corneal stroma, and aqueous outflow system in the larval eye, but foxd3 was no 
longer expressed in the adult anterior segment. Additional studies are required to 
determine the ultimate fate of these cells in the adult eye. Thus, foxd3 is a marker that 
demarcates the ocular population of cranial neural crest cells. These studies were 
necessary for determining differences in ETOH sensitivity between the craniofacial and 
ocular neural crest populations.  
The majority of animal studies focusing on ETOH and ocular development 
highlight the teratogenic effects on the neuroepithelial-derived optic nerve and retina. 
These previous studies have recapitulated optic nerve hypoplasia and microphthalmia 
in different animal models, but have not determined the effect of ETOH on the neural 
crest cells that contribute to the anterior segment (Cook et al., 1987;Phillips et al., 
1991;Pinazo-Duran et al., 1993;Stromland and Pinazo-Duran, 2002). In the present 
study, we observed that the survival and migration of foxd3-positive neural crest cells in 
the eye were less sensitive to ETOH compared with their sox10-positive counterparts 
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ledestined for craniofacial structures. This difference may in part reflect the increased resistance of periocular and ocular neural crest cells to ROS generation in response to 
ETOH exposure. Numerous studies have linked the cellular effects of alcohol to 
increased oxidative stress in both adult and embryonic tissues (Chu et al., 2007;Heaton 
et al., 2002;Henderson et al., 1995;Koch et al., 1991;Koch et al., 2004;Videla et al., 
1983). The cranial neural crest and developing brain have relatively low levels of 
antioxidant enzymes compared to the liver or kidneys, making these tissues more 
susceptible to free radical damage (Chen et al., 2000;Davis et al., 1990;Floyd and 
Carney, 1992). Indeed, supplementation with antioxidants has been shown to decrease 
the craniofacial and neurological phenotypes in animal models of FAS (Heaton et al., 
2000;Joya et al., 2015;Wentzel and Eriksson, 2006). Ethanol predominantly increases 
oxidative stress within mitochondria, and as a result, there is a compensatory increase 
in the expression of the mitochondrial form of superoxide dismutase (sod2) in adult 
tissues (Koch et al., 1994;Koch et al., 2000). Similarly, rat cranial neural crest cells 
exposed to ETOH show an increase in Sod2, but not the soluble (Sod1) or extracellular 
(Sod3) forms (Chen and Sulik, 1996;Wentzel and Eriksson, 2006). The results of the 
present study further revealed that low levels of ETOH, which did not disrupt neural 
crest migration into the eye, increased the expression of the antioxidant enzyme, sod2. 
Interestingly, this enzyme, which  was highly expressed in the developing anterior 
segment and . knockdown of Sod2 resulted in increased sensitivity of the ocular neural 
crest to these low levels of ETOH. In contrast, ETOH decreased the expression of sod1 
and sod3, which were expressed in the retina and facial mesenchyme. This suggests a 
model in which Sod2 has a protective effect against oxidative stress in the developing 
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leanterior segment and this may account for the decreased sensitivity of the ocular neural crest to ETOH exposure compared to craniofacial neural crest.  
 Thus, the microenvironments of the periocular mesenchyme and developing 
anterior segment may be more protective against ROS compared to those of the retina 
and craniofacial structures.    
The migration, proliferation and differentiation of neural crest cells that enter into the eye 
are also regulated through interactions with the optic cup. Retinoic acid is a key 
regulator that mediates signaling between the developing retina and periocular neural 
crest. In mice, chickens and zebrafish, periocular retinoic acid is produced in the 
developing dorsal and ventral retina (Bohnsack et al., 2012;Molotkov et al., 2006;Suzuki 
et al., 2000). The retinoic acid receptors (RAR) α, β, and γ are expressed in the 
periocular mesenchyme, and retinoic acid signaling regulates neural crest cell survival 
and migration via the expression of Pitx2 and Foxc1 (Bohnsack et al., 2012;Dupe et al., 
1999;Kumar and Duester, 2010;Matt et al., 2005;Matt et al., 2008). Further, tight control 
of retinoic acid levels is required for proper formation of the iris stroma and cornea in the 
anterior segment (Bohnsack et al., 2012).{Bohnsack, 2012 #64} Retinoic acid has been 
identifiedis hypothesized to be as a putative target of ethanol through the competitive 
inhibition of the retinoic acid synthesis enzyme, retinol dehydrogenase (Deltour et al., 
1996). In zebrafish, retinoic acid together with sonic hedgehog can rescue certain 
phenotypes associated with ethanol exposure, including brain abnormalities, 
microphthalmia, and retinal differentiation (Muralidharan et al., 2015;Zhang et al., 2016). 
However, these FAS phenotypes result from neuroepithelial cell anomalies and not 
neural crest defects. Less is known about the effects of ethanol on retinoic acid in the 
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leneural crest, particularly neural crest cell populations in the periocular mesenchyme and developing eye. However, in the present study expression of pitx2a and foxc1a, which 
are known targets of retinoic acid, was minimally affected by ETOH exposure 
suggesting that ETOH may not regulate retinoic acid signaling in the periocular 
mesenchyme. In the present study, the expression of pitx2a and foxc1a in the periocular 
mesenchyme was minimally affected by ETOH. The only transcription factor affected by 
ETOH was foxc1b, which is predominantly expressed in the facial mesenchyme and not 
in the eye. Prior studies have shown that pitx2 and foxc1 are critical for neural crest 
migration and anterior segment formation (Berry et al., 2008;Bohnsack et al., 
2012;Chawla et al., 2016;Evans and Gage, 2005;Gage et al., 1999;Kume et al., 
2000;Skarie and Link, 2009). Clinically, gain- or loss-of-function mutations of either of 
these genes are most commonly associated with Axenfeld-Rieger syndrome, an 
autosomal dominant congenital disease characterized by anterior segment dysgenesis 
and craniofacial abnormalities (Leis et al., 2012;Strungaru et al., 2007;Tumer and Bach-
Holm, 2009). Taken together, these studies further demonstrated that the neural crest 
cells around and within the developing eye are more robust to the effects of ETOH and 
maintain the molecular signals required for anterior segment formation.  
 The present study assessed the cellular and molecular effects of ETOH on the 
neural crest cells that form the anterior segment of the eye. Consistent with the rarity of 
anterior segment abnormalities associated with FAS, the neural crest cell populations in 
the periocular mesenchyme and within the developing eye were less sensitive to ETOH 
exposure compared to the neural crest that gives rise to the jaw and pharyngeal arches. 
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leThese studies provide further insight into the pathogenesis of congenital anomalies and the effects of prenatal alcohol exposure on craniofacial and ocular development.  
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leFIGURE LEGENDS Fig. 1. Sox10 and foxd3 demarcated temporally and spatially distinct neural crest 
cells. Live imaging and lateral section immunofluorescence (IF) of 24 to 60 hpf 
Tg(sox10:mRFP), Tg(foxd3:GFP) and Tg(sox10:mRFP; foxd3:GFP) embryos showed 
the expression and migration patterns of sox10 and foxd3-positive cells in the periocular 
mesenchyme and developing anterior segment. Sox10 was highly expressed in the 
periocular mesenchyme at 24 hpf (A, A’’), but showed decreased expression by 60 hpf 
(B-D, B’’-D’’). A small proportion of sox10-positive cells migrated into the eye between 
the surface ectoderm and optic cup from 24 to 48 hpf (A-C, A’’-C’’). Few sox10-positive 
cells were observed in the anterior segment at 60 hpf (D). Ventral live imaging (E) and 
coronal IF sections (F) showed sox10-positive cells in the craniofacial structures 
(pharyngeal arches (PA), ceratohyal cartilage (Ch), and Meckel’s cartilage (Mk)), but not 
in the developing anterior segment, at 96 hpf. Foxd3-positive cells predominantly 
migrated into the anterior segment in the dorsal (d) –posterior (p) quadrant between the 
surface ectoderm and optic cup from 30 to 60 hpf (A’-D’). In addition, foxd3-positive 
cells migrated through the ocular fissure between 30 and 48 hpf (arrows, B’, B’’, C’, C’’). 
At 96 hpf, foxd3 expression (E’, F’) was localized to the iris stroma (closed arrow), 
cornea (open arrow), and aqueous outflow tracts (closed arrow head), but was not 
expressed in the pharyngeal arches, Meckel’s cartilage or ceratohyal cartilage. Foxd3 
was expressed in retinal photoreceptors (open arrowhead, D’, E’, F’) at 96after 60 hpf, 
but this expression was not related to neural crest cells. Section analysis showed little 
overlap in expression of sox10 and foxd3 in neural crest cells entering the anterior 
segment (A’’-D’’). a, anterior; d, dorsal; p, posterior; v, ventral. 
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leFig. 2. ETOH treatment from 24 to 48 hpf did not significantly affect embryonic survival, but did inhibit eye size. Treatment with 0.5%, 1% or 3% ETOH from 24 to 48 
hpf did not significantly increase the percentage of embryo death assessed at 72 hpf 
(A). Treatment with 0.5% or 1% ETOH did not significantly affect the length (in µm) of 
the eye in either the dorsal-ventral or anterior-posterior axis (B). However, treatment 
with 3% ETOH significantly decreased the eye size in both the dorsal-ventral and 
anterior-posterior axes compared to untreated embryos (B). *, p<0.05 
 
Fig. 3. Craniofacial neural crest cells were more sensitive to ETOH than periocular 
and ocular neural crest cells. Live imaging of Tg(foxd3:GFP) embryos from 24 (A) to 
7260 hpf demonstrated that treatment with 1% ETOH from 24 to 48 hpf (B’-E’G-I) did 
not alter the migration of foxd3-positive cells between the surface ectoderm and optic 
cup (closed arrows) or through the ocular fissure (open arrows) compared to untreated 
controls (B-ED). In addition, 1% ETOH did not affect the number of foxd3-positive cells 
in the periocular mesenchyme (closed arrowheads in B’-D’, H). Methylacrylate sections 
of 96 hpf embryos showed that 1% ETOH treatment from 24-48 hpf did not affect iris 
stroma cellularity (arrowheads, F’J) compared to untreated embryos (FE). In contrast, 
live imaging of Tg(sox10:EGFP) embryos at 96 hpf showed that treatment with 1% 
ETOH from 24 to 48 hpf (G’K) delayed Meckel’s (Mk) cartilage, ceratohyal (CH), and 
pharyngeal arch (PA) cartilage formation compared to untreated controls (GF). 
Treatment with 3% ETOH from 24 to 48 hpf caused developmental delay by 36 hpf 
(B’’L) and at 48 hpf significantly decreased the number of , but foxd3-positive cells were 
present in the periocular mesenchyme (closed arrowhead in , C’’, HL-N). Further, there 
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lewere fewer foxd3-positive cells  and migrated into thein the developing eye (closed and open arrows, B’’-E’’) of 36 to 72 hpf embryos treated with 3% ETOH, L-N).  However, 
aAnalysis of methylacrylate sections at 96 hpf  revealed that the eyes in embryos 
treated with 3% ETOH from 24 to 48 hpf were significantly smaller (F’’O) showed that, 
and  although neural crest cells were present in the iris stroma (closed arrowheads) and 
corneal stroma (arrows), though the corneas were thickened and the lenses were 
misshapen. Treatment with 3% ETOH inhibited sox10-positive neural crest cell-derived 
pharyngeal arch formation and resulted in ceratohyal and Meckel’s cartilage 
malformation (G’’P).  
 
Fig. 4. ETOH increased apoptosis in craniofacial neural crest cells but not ocular 
neural crest cells. TUNEL assay on sections from 27 to 48 hpf Tg(sox10:EGFP) or 
Tg(foxd3:GFP) embryos demonstrated that treatment with 1% ETOH starting at 24 hpf 
caused a transient increase in apoptosis within the eye at 30 (C’, D’) and 33 (E’, F’) hpf 
compared to untreated embryos (C-F). The apoptosis was not localized to either sox10-
positive or foxd3-positive cells within the eye. In contrast, 1% ETOH did not affect cell 
survival in the developing eye at 27 (A’, B’), 36 (G’, H’), or 48 (I’, J’) hpf. Treatment with 
3% ETOH starting at 24 hpf caused a significant decrease in cell survival within the eye 
(A’’-H’’), but this apoptosis was not specifically localized to sox10- or foxd3-positive cells 
in the ocular neural crest. In contrast, 1% or 3% ETOH increased apoptosis in sox10-
positive cells (closed arrowhead, E’’, I’) in the facial mesenchyme (closed arrowhead, F’ 
and H’). 
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le Fig. 5. ETOH significantly increased apoptosis within the developing eye. 
Treatment with 1% ETOH from 24 to 48 hpf showed a transient increase in the 
percentage of apoptotic cells within the developing eye at 30 and 33 hpf. Treatment with 
3% ETOH significantly increased the percentage of apoptotic cells in the eye after 6 
hours, and this effect continued through 48 hpf.  
 
Fig. 6. Ethanol increased oxidative stress in the facial mesenchyme, but not in the 
anterior segment. Tg(sox10:mRFP) embryos showed that 1% or 3% ETOH treatment 
starting at 24 hpf increased ROS in sox10-positive cells in the facial mesenchyme 
(arrows, B, C) within 2 hours of treatment compared to untreated controls (A). Semi-
quantitative RT-PCR (D) showed that 1% ETOH starting at 24 hpf decreased the 
expression of sod1 and sod3, but increased the expression of sod2 in RNA isolated 
from whole 48 hpf embryos. Treatment with 3% ETOH from 24 to 48 hpf decreased the 
expression of sod1, sod2, and sod3. Following Iin situ hybridization , sections of 36 hpf 
embryos demonstrated that sod1 (DE, DE’) and sod3 (FG, FG’) were expressed in the 
hyaloid vasculature (arrowhead) and retina in the eye, the periocular mesenchyme, and 
the facial mesenchyme (open arrow). Sod2 was also expressed in the periocular 
mesenchyme and hyaloid vasculature (arrowhead, EF). In addition, sod2 was 
expressed in the anterior segment of the eye (EF’) in lens epithelial cells and neural 
crest cells between the optic cup and surface ectoderm (arrow). Semi-quantitative RT-
PCR (GD) of RNA derived from whole 48 hpf embryos showed that 1% ETOH starting 
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leat 24 hpf decreased the expression of sod1 and sod3, but increased the expression of sod2 in RNA isolated from whole 48 hpf embryos. Treatment with 3% ETOH from 24 to 
48 hpf decreased the expression of sod1, sod2, and sod3. Immunohistochemistry 
confirmed the expression of Sod2 protein in the anterior segment (arrows, I). Sod2 
protein expression was increased by 1% ETOH (I’), but decreased by 3% ETOH (I’’). 
Knockdown of Sod2 by MO injection showed decreased protein expression in untreated 
(J), 1% ETOH-treated (J’), and 3% ETOH-treated (J’’) embryos.  
Fig. 7. Sod2 decreases effects of ETOH on ocular neural crest and anterior 
segment development.  
Live imaging of Tg(foxd3:GFP) embryos showed that foxd3-positive cell migration into 
the anterior segment between 36 and 72 hpf was not affected by Sod2 MO knockdown 
(arrows, Fig. 7E-7H) compared to mismatch control-injected (Fig. 7A-7D) embryos. 
Knockdown of Sod2 in combination with 1% ETOH treatment from 24 to 48 hpf 
decreased foxd3-positive neural crest cell migration into the anterior segment (arrows, 
Fig. 7E’-7H’), but did not affect the cells in the periocular mesenchyme (arrowheads). 
This was in contrast to mismatch control-injected (Fig. 7A’-7D’) embryos in which 1% 
ETOH did not affect foxd3-positive cells in the periocular mesenchyme (arrowheads) or 
in the anterior segment migration (arrows). Treatment with 3% ETOH between 24 and 
48 hpf decreased foxd3-positive cells in the periocular mesenchyme and in the 
developing eye in Sod2 knockdown (Fig. 7E’’-7H’’) and mismatch control-injected (Fig. 
7A’’-D’’) embryos.  
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leFig. 87. Ethanol had a minimal effect on the expression of periocular and ocular genes associated with congenital eye diseases. Semi-quantitative RT-PCR showed 
that 1% or 3% ETOH treatment from 24 to 48 hpf had minimal effect on expression of 
pitx2a, and foxc1a in RNA isolated from whole 48 hpf embryos. Foxc1b expression was 
decreased after treatment with 3% ETOH, but not 1% ETOH. Whole mount in situ 
hybridization in untreated (B), 1% ETOH treated (B’), and 3% ETOH treated (B’’) 48 hpf 
embryos demonstrated that pitx2a was expressed in the pituitary (open arrowsyellow 
arrows), periocular mesenchyme, heart (arrowhead) and the periocular mesenchyme 
(arrow)and the ocular fissure (open arrows). Foxc1a was expressed in the facial 
mesenchyme (arrowhead), periocular mesenchyme (yellow arrows), and hyaloid 
vasculature in the ocular fissure (open arrowsarrow) of untreated (C), 1% ETOH treated 
(C’), and 3% ETOH treated (C’’) 48 hpf embryos. Similar to foxc1a, foxc1b was 
expressed in the facial mesenchyme (arrowheadblack arrows) and periocular 
mesenchyme (open arrows), but not in the ocular fissure of untreated (D) and 1% ETOH 
treated (D’) 48 hpf embryos. Treatment with 3% ETOH decreased foxc1b expression 
(D’’) in the facial mesenchyme and periocular mesenchyme. 
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Fig. 1. Sox10 and foxd3 demarcated temporally and spatially distinct neural crest cells. Live imaging and 
lateral section immunofluorescence (IF) of 24 to 60 hpf Tg(sox10:mRFP), Tg(foxd3:GFP) and 
Tg(sox10:mRFP; foxd3:GFP) embryos showed the expression and migration patterns of sox10 and foxd3-
positive cells in the periocular mesenchyme and developing anterior segment. Sox10 was highly expressed 
in the periocular mesenchyme at 24 hpf (A, A’’), but showed decreased expression by 60 hpf (B-D, B’’-D’’). 
A small proportion of sox10-positive cells migrated into the eye between the surface ectoderm and optic cup 
from 24 to 48 hpf (A-C, A’’-C’’). Few sox10-positive cells were observed in the anterior segment at 60 hpf 
(D). Ventral live imaging (E) and coronal IF sections (F) showed sox10-positive cells in the craniofacial 
structures (pharyngeal arches (PA), ceratohyal cartilage (Ch), and Meckel’s cartilage (Mk)), but not in the 
developing anterior segment, at 96 hpf. Foxd3-positive cells predominantly migrated into the anterior 
segment in the dorsal (d)–posterior (p) quadrant between the surface ectoderm and optic cup from 30 to 60 
hpf (A’-D’). In addition, foxd3-positive cells migrated through the ocular fissure between 30 and 48 hpf 
(arrows, B’, B’’, C’, C’’). At 96 hpf, foxd3 expression (E’, F’) was localized to the iris stroma (closed arrow), 
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cornea (open arrow), and aqueous outflow tracts (closed arrow head), but was not expressed in the 
pharyngeal arches, Meckel’s cartilage or ceratohyal cartilage. Foxd3 was expressed in retinal photoreceptors 
(open arrowhead, E’, F’) at 96 hpf, but this expression was not related to neural crest cells. Section analysis 
showed little overlap in expression of sox10 and foxd3 in neural crest cells entering the anterior segment 
(A’’-D’’). a, anterior; d, dorsal; p, posterior; v, ventral.  
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Fig. 2. ETOH treatment from 24 to 48 hpf did not significantly affect embryonic survival, but did inhibit eye 
size. Treatment with 0.5%, 1% or 3% ETOH from 24 to 48 hpf did not significantly increase the percentage 
of embryo death assessed at 72 hpf (A). Treatment with 0.5% or 1% ETOH did not significantly affect the 
length (in µm) of the eye in either the dorsal-ventral or anterior-posterior axis (B). However, treatment with 
3% ETOH significantly decreased the eye size in both the dorsal-ventral and anterior-posterior axes 
compared to untreated embryos (B). *, p<0.05.  
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Fig. 3. Craniofacial neural crest cells were more sensitive to ETOH than periocular and ocular neural crest 
cells. Live imaging of Tg(foxd3:GFP) embryos from 24 (A) to 72 hpf demonstrated that treatment with 1% 
ETOH from 24 to 48 hpf (B’-E’) did not alter the migration of foxd3-positive cells between the surface 
ectoderm and optic cup (closed arrows) or through the ocular fissure compared to untreated controls (B-E). 
In addition, 1% ETOH did not affect the number of foxd3-positive cells in the periocular mesenchyme 
(closed arrowheads in B’-D’, H). Methylacrylate sections of 96 hpf embryos showed that 1% ETOH treatment 
from 24-48 hpf did not affect iris stroma cellularity (arrowheads, F’) compared to untreated embryos (F). In 
contrast, live imaging of Tg(sox10:EGFP) embryos at 96 hpf showed that treatment with 1% ETOH from 24 
to 48 hpf (G’) delayed Meckel’s (Mk) cartilage, ceratohyal (CH), and pharyngeal arch (PA) cartilage 
formation compared to untreated controls (G). Treatment with 3% ETOH from 24 to 48 hpf caused 
developmental delay by 36 hpf (B’’) and at 48 hpf significantly decreased the number of foxd3-positive cells 
present in the periocular mesenchyme (closed arrowhead in C’’, H). Further, there were fewer foxd3-positive 
cells in the developing eye (closed arrows, B’’-E’’) of 36 to 72 hpf embryos treated with 3% ETOH. However, 
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analysis of methylacrylate sections at 96 hpf (F’’) showed that neural crest cells were present in the iris 
stroma (closed arrowheads) and corneal stroma (arrows), though the corneas were thickened and the lenses 
were misshapen. Treatment with 3% ETOH inhibited sox10-positive neural crest cell-derived pharyngeal 
arch formation and resulted in ceratohyal and Meckel’s cartilage malformation (G’’).  
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Fig. 4. ETOH increased apoptosis in craniofacial neural crest cells but not ocular neural crest cells. TUNEL 
assay on sections from 27 to 48 hpf Tg(sox10:EGFP) or Tg(foxd3:GFP) embryos demonstrated that 
treatment with 1% ETOH starting at 24 hpf caused a transient increase in apoptosis within the eye at 30 (C’, 
D’) and 33 (E’, F’) hpf compared to untreated embryos (C-F). The apoptosis was not localized to either 
sox10-positive or foxd3-positive cells within the eye. In contrast, 1% ETOH did not affect cell survival in the 
developing eye at 27 (A’, B’), 36 (G’, H’), or 48 (I’, J’) hpf. Treatment with 3% ETOH starting at 24 hpf 
caused a significant decrease in cell survival within the eye (A’’-H’’), but this apoptosis was not specifically 
localized to sox10- or foxd3-positive cells in the ocular neural crest. In contrast, 1% or 3% ETOH increased 
apoptosis in sox10-positive cells (closed arrowhead, E’’, I’) in the facial mesenchyme (closed arrowhead, F’ 
and H’).  
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Fig. 5. ETOH significantly increased apoptosis within the developing eye. Treatment with 1% ETOH from 24 
to 48 hpf showed a transient increase in the percentage of apoptotic cells within the developing eye at 30 
and 33 hpf. Treatment with 3% ETOH significantly increased the percentage of apoptotic cells in the eye 
after 6 hours, and this effect continued through 48 hpf.  
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Fig. 6. Ethanol increased oxidative stress in the facial mesenchyme, but not in the anterior segment. 
Tg(sox10:mRFP) embryos showed that 1% or 3% ETOH treatment starting at 24 hpf increased ROS in 
sox10-positive cells in the facial mesenchyme (arrows, B, C) within 2 hours of treatment compared to 
untreated controls (A). In situ hybridization of 36 hpf embryos demonstrated that sod1 (D, D’) and sod3 (F, 
F’) were expressed in the hyaloid vasculature (arrowhead) and retina in the eye, the periocular 
mesenchyme, and the facial mesenchyme (open arrow). Sod2 was also expressed in the periocular 
mesenchyme and hyaloid vasculature (arrowhead, E). In addition, sod2 was expressed in the anterior 
segment of the eye (E’) in lens epithelial cells and neural crest cells between the optic cup and surface 
ectoderm (arrow). Semi-quantitative RT-PCR (G) of RNA derived from whole 48 hpf embryos showed that 
1% ETOH starting at 24 hpf decreased the expression of sod1 and sod3, but increased the expression of 
sod2. Treatment with 3% ETOH from 24 to 48 hpf decreased the expression of sod1, sod2, and sod3. 
Immunohistochemistry confirmed the expression of Sod2 protein in the anterior segment (arrows, I). Sod2 
protein expression was increased by 1% ETOH (I’), but decreased by 3% ETOH (I’’). Knockdown of Sod2 by 
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MO injection showed decreased protein expression in untreated (J), 1% ETOH-treated (J’), and 3% ETOH-
treated (J’’) embryos.  
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Fig. 7. Sod2 decreases effects of ETOH on ocular neural crest and anterior segment development. Live 
imaging of Tg(foxd3:GFP) embryos showed that foxd3-positive cell migration into the anterior segment 
between 36 and 72 hpf was not affected by Sod2 MO knockdown (arrows, Fig. 7E-7H) compared to 
mismatch control-injected (Fig. 7A-7D) embryos. Knockdown of Sod2 in combination with 1% ETOH 
treatment from 24 to 48 hpf decreased foxd3-positive neural crest cell migration into the anterior segment 
(arrows, Fig. 7E’-7H’), but did not affect the cells in the periocular mesenchyme (arrowheads). This was in 
contrast to mismatch control-injected (Fig. 7A’-7D’) embryos in which 1% ETOH did not affect foxd3-positive 
cells in the periocular mesenchyme (arrowheads) or in the anterior segment migration (arrows). Treatment 
with 3% ETOH between 24 and 48 hpf decreased foxd3-positive cells in the periocular mesenchyme and in 
the developing eye in Sod2 knockdown (Fig. 7E’’-7H’’) and mismatch control-injected (Fig. 7A’’-D’’) 
embryos.  
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Fig. 8. Ethanol had a minimal effect on the expression of periocular and ocular genes associated with 
congenital eye diseases. Semi-quantitative RT-PCR showed that 1% or 3% ETOH treatment from 24 to 48 
hpf had minimal effect on expression of pitx2a, and foxc1a in RNA isolated from whole 48 hpf embryos. 
Foxc1b expression was decreased after treatment with 3% ETOH, but not 1% ETOH. Whole mount in situ 
hybridization in untreated (B), 1% ETOH treated (B’), and 3% ETOH treated (B’’) 48 hpf embryos 
demonstrated that pitx2a was expressed in the pituitary (yellow arrows), periocular mesenchyme, and the 
ocular fissure (open arrows). Foxc1a was expressed in the facial mesenchyme, periocular mesenchyme 
(yellow arrows), and in the ocular fissure (open arrows) of untreated (C), 1% ETOH treated (C’), and 3% 
ETOH treated (C’’) 48 hpf embryos. Similar to foxc1a, foxc1b was expressed in the facial mesenchyme 
(black arrows) and periocular mesenchyme (open arrows), but not in the ocular fissure of untreated (D) and 
1% ETOH treated (D’) 48 hpf embryos. Treatment with 3% ETOH decreased foxc1b expression (D’’) in the 
facial mesenchyme and periocular mesenchyme.  
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ABSTRACT:  
Background: Ethanol (ETOH) exposure during pregnancy is associated with 
craniofacial and neurologic abnormalities, but infrequently disrupts the anterior segment 
of the eye. In these studies, we used zebrafish to investigate differences in the 
teratogenic effect of ETOH on craniofacial, periocular, and ocular neural crest. 
Methods: Zebrafish eye and neural crest development was analyzed via live imaging, 
TUNEL assay, immunostaining, detection of reactive oxygen species, and in situ 
hybridization. 
Results: Our studies demonstrated that foxd3-positive neural crest cells in the 
periocular mesenchyme and developing eye were less sensitive to ETOH than sox10-
positive craniofacial neural crest cells that form the pharyngeal arches and jaw. ETOH 
increased apoptosis in the retina, but did not affect survival of periocular and ocular 
neural crest cells. ETOH also did not increase reactive oxygen species within the eye. 
In contrast, ETOH increased ventral neural crest apoptosis and reactive oxygen species 
production in the facial mesenchyme. In the eye and craniofacial region, sod2 showed 
high levels of expression in the anterior segment and in the setting of Sod2 knockdown, 
low levels of ETOH decreased migration of foxd3-positive neural crest cells into the 
developing eye. However, ETOH had minimal effect on the periocular and ocular 
expression of transcription factors (pitx2 and foxc1) that regulate anterior segment 
development.  
Conclusions: Neural crest cells contributing to the anterior segment of the eye exhibit 
increased ability to withstand ETOH-induced oxidative stress and apoptosis. These 
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studies explain the rarity of anterior segment dysgenesis despite the frequent 
craniofacial abnormalities in fetal alcohol syndrome. 
Keywords: Neural crest, fetal alcohol syndrome, eye development, anterior segment, 
superoxide dismutase, ethanol, congenital eye disease  
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INTRODUCTION 
 Fetal alcohol spectrum disorders refer to the range of multi-systemic anomalies 
resulting from alcohol consumption during pregnancy (Hoyme et al., 2005;Jones et al., 
1973;Lemoine et al., 2003;Riley et al., 2011;Sokol, 2003). The most severe 
manifestation in this spectrum is referred to as fetal alcohol syndrome (FAS) and 
includes a combination of growth retardation, neurological deficits, and craniofacial 
malformations. The neuroepithelium, which forms the central nervous system, and the 
cranial neural crest, which gives rise to the bone and connective tissue of the 
craniofacial region, are tissues that are highly sensitive to the effects of ethanol 
(ETOH)(Clarren et al., 1978;Kiecker, 2016;Lovely et al., 2016;Mattson and Riley, 
1996;Sampson et al., 1997). In humans and animals, the effects of ETOH on brain and 
cranial neural crest development are closely related to the duration and concentration of 
exposure (Joya et al., 2014;Kiecker, 2016;Riley et al., 2011;Sulik et al., 1981;Zhang et 
al., 2014). Numerous studies have demonstrated that ETOH alters the patterning of the 
neuroepithelium resulting in the inhibition of neuronal induction, proliferation and 
survival (Dunty et al., 2002;Maier et al., 1997;Maier et al., 1999;Parnell et al., 2009;Sulik 
et al., 1984;Zhang et al., 2016). These alterations commonly disrupt neurological 
function and behavior, and in severe cases, lead to structural abnormalities, such as 
agenesis of the corpus callosum and cerebellar hypoplasia (Hoyme et al., 
2005;Lemoine et al., 2003;Mattson and Riley, 1996;Riley et al., 2011;Sokol, 2003). In 
the adjacent neural crest, early exposure to ETOH decreases delamination, inhibits 
proliferation, decreases survival, and alters migration (Flentke et al., 2011;Garic et al., 
2011;Garic-Stankovic et al., 2005;Smith et al., 2014;Tolosa et al., 2016), resulting in the 
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classic craniofacial anomalies associated with FAS (e.g. thin vermillion, shortened 
palpebral fissures, and smooth philtrum), and also causing cleft lip and cleft palate in 
severe cases (Foroud et al., 2012;Hoyme et al., 2005;Klingenberg et al., 2010;Riley et 
al., 2011).  
The cranial neural crest, which arises from the prosencephalon, mesencephalon, 
and rhombencephalon, follows specific migratory pathways into the craniofacial region 
(Bohnsack and Kahana, 2013;Chawla et al., 2016;Trainor, 2005;Trainor and Tam, 
1995). At the same time that the jaw and pharyngeal arches are forming, a subgroup of 
neural crest cells, which initially populates the periocular mesenchyme, enters the eye 
(Creuzet et al., 2005;Johnston, 1966;Johnston et al., 1979). In other congenital 
disorders (e.g. Axenfeld-Rieger Syndrome and Peters Plus Syndrome), craniofacial 
anomalies are associated with malformations of the anterior segment of the eye (Aliferis 
et al., 2010;Dressler et al., 2010;Lesnik Oberstein et al., 2006;Ozeki et al., 
1999;Schoner et al., 2013;Strungaru et al., 2007;Tumer and Bach-Holm, 2009). 
Interestingly, corneal, iris, and angle abnormalities are a rare manifestation of FAS 
(Brennan and Giles, 2014;Chan et al., 1991;Edward et al., 1993;Miller et al., 
1984;Stromland, 1987). The molecular differences between neural crest cells that give 
rise to craniofacial structures versus neural crest cells that form the anterior segment 
are not well defined. Differences in sensitivity to ETOH suggest that the periocular and 
ocular neural crest are molecularly distinct from the craniofacial neural crest. Although 
numerous studies have investigated the effect of ETOH on the cranial neural crest in 
facial development, few studies have focused on the periocular and ocular populations. 
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In the present study, we used a zebrafish model of FAS to investigate the effects 
of ETOH exposure on the periocular and ocular neural crest. The neural crest cells that 
enter the eye have been difficult to study, reflecting their transient nature and the lack of 
adequate markers to track this migrating population. We identified foxd3 as a marker for 
these cells within zebrafish embryos and larvae in contrast to sox10, which was 
predominantly detected in craniofacial neural crest cells. Using these 2 markers, we 
investigated differences in cell survival, reactive oxygen species (ROS) production and 
gene expression in response to ETOH exposure in these neural crest cell populations.  
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MATERIALS AND METHODS: 
Animal Care/Animal Strains 
Zebrafish (Danio rerio) were raised in a breeding colony under a 14-h light/10-h 
dark cycle as previously described (Bohnsack et al., 2011a;Bohnsack et al., 
2011b;Bohnsack and Kahana, 2013;Bohnsack et al., 2012;Chawla et al., 2016). 
Embryos were maintained at 28.5 degrees Celsius and staged as previously described 
(Kimmel et al., 1995). The transgenic strains Tg(sox10:EGFP), Tg(sox10:mRFP), and 
Tg(foxd3:GFP) were gifts from Thomas Schilling, Cunming Duan, and Mary Halloran, 
respectively, and the strains were crossed into the Roy (roy -/-) or Casper (roy -/-, nacre 
-/-) background to decrease auto-fluorescence and interference resulting from 
pigmentation (Curran et al., 2009;Dutton et al., 2001a;Dutton et al., 2001c;Kucenas et 
al., 2008). Animal protocols were performed in accordance with the guidelines for the 
humane treatment of laboratory animals established by the University of Michigan 
Committee on the Use and Care of Animals (IACUC, protocol #10205) and the ARVO 
(Association for Research in Vision and Ophthalmology) Statement for the Use of 
Animals in Ophthalmic and Vision Research.  
 
Imaging 
Whole embryos were analyzed using a M205FA combi-scope (Leica 
Microsystems CMS GmbH, Germany, Wetzler, Germany). Images were obtained using 
brightfield DFC290 (Leica) and fluorescent ORCA-ER (Hamamatsu, Hamamatsu City, 
Japan) cameras. The sections were imaged using a DM6000B upright microscope 
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(Leica) equipped with a DFC500 camera (Leica). The images were processed and 
analyzed using Adobe Photoshop (San Jose, CA, USA), LAS X  (Leica) and/or LAS 
AF6000 software (Leica). The images shown are representative of all experiments. For 
quantifying the number of foxd3-positive periocular mesenchymal and ocular neural 
crest cells, z-stacks that ranged from the lateral edge of the cornea to 100 µm medial to 
the medial edge of the eye were obtained. The z-stacks were deconvolved and 
maximally projected in order to obtain a single image. The number of foxd3-positive 
cells was manually counted. Eye size was measured from the dorsal to ventral border in 
a lateral view and from the anterior to posterior border in a ventral view. Measurements 
were obtained from bilateral eyes of 4-6 embryos at each time point for each group. The 
data were statistically analyzed using ANOVA with Tukey’s post-hoc analysis, and 
p<0.05 was considered statistically significant. 
 
Pharmacological treatments 
Absolute ethanol (ETOH, Sigma-Aldrich, St. Louis, MO, USA) was administered 
in the embryo media at 0.5-3%. The embryos were dechorionated, and the treatments 
were administered from 24 to 48 hours post fertilization (hpf). Following treatment, the 
embryos were washed multiple times with embryo media and subsequently placed in 
fresh embryo media for the remainder of the time course as indicated. Experiments 
utilized 50-100 embryos per treatment group and were replicated 4-6 times. Phenotypes 
were assessed at 36, 48, 60, and 72 hpf. Data were statistically analyzed using ANOVA 
with Tukey’s post-hoc analysis. A p value of <0.5 was considered statistically significant.  
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Morpholino Oligonucleotide Injections 
Translation blocking (GAACATATCCGACTCTGCACAGCAT) and 5-basepair 
mismatch control (GAAGAAATCGGACTCTCCACACCAT) antisense morpholino 
oligonucleotides (MO; Gene Tools, LLC Cowallis, OR) directed against zebrafish Sod2 
were reconstituted in de-ionized water. The sequences for the MO were previously 
published (Peterman et al., 2015). Concentrations yielding consistent and reproducible 
phenotypes were determined for each MO. One-cell stage embryos were injected with 
1-2 nL of MO at a concentration of 0.25 mM (2.1ng/nl). Embryos were imaged at 24, 36, 
48, and 60 hpf as described above.  
 
Methylacrylate sections 
Zebrafish embryos at 96 hpf were fixed in 2% paraformaldehyde/1.5% 
glutaraldehyde overnight at 4 degrees Celsius, followed by embedding in 
methylacrylate. The blocks were sectioned at 5 µm. The sections were stained with 
Lee’s stain and imaged as described above.  
 
Immunostaining and TUNEL assay 
The staged zebrafish embryos were fixed in 4% paraformaldehyde overnight at 4 
degrees Celsius. Wholemount immunostaining for green fluorescent protein (GFP) and 
terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays were 
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performed as previously described using standard protocols (Bohnsack and Kahana, 
2013). Briefly, apoptotic cells were detected through the TdT-mediated incorporation of 
digoxigenin-labeled deoxyuridine triphosphate. Sheep anti-digoxigenin conjugated to 
rhodamine was used to detect the TUNEL signal. The embryos were subsequently 
incubated with mouse anti-GFP directly conjugated to FITC (1:200, Millipore, Billerica, 
MA, USA). The embryos were cryoprotected in successive sucrose solutions, 
embedded in Optimal Cutting Temperature (O.C.T) compound, and subsequently 
sectioned at 10 µm. The sections were co-stained with DAPI and imaged as described 
above. For quantification of the percentage of cells undergoing apoptosis in the eye at 
48 hpf, 3 consecutive sections through the equator of the lenses of at least 4 embryos 
per group were included. The number of cell nuclei as marked by DAPI staining and the 
number of TUNEL-positive cells in the eyes were manually counted. The data were 
statistically analyzed using ANOVA with Tukey’s post hoc analysis, and p<0.05 was 
considered statistically significant. 
For Sod2 immunostaining, embryos were harvested at 48 hpf, fixed in 4% 
paraformaldehyde and cryoprotected in successive sucrose solutions. Embryos were 
embedded in O. C. T compound and sectioned at 10 µm. The sections were washed in 
PBS, dehydrated in acetone, and blocked in 10% normal goat serum in PBS with 0.1% 
triton. Sections were incubated with anti-Sod2 (1:100, Genetex, Irvine, CA, USA) 
overnight at 4 degrees Celsius. The sections were washed in PBS and then incubated 
with goat anti-rabbit secondary antibody conjugated to Cy3 (1:1000, Abcam, 
Cambridge, MA, USA) for 2 hours at room temperature. The sections were washed, 
costained with DAPI, and imaged as described above.  
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Detection of Reactive Oxygen Species (ROS) 
 Tg(sox10:mRFP) embryos were incubated with CellROX Green Reagent 
(Molecular Probes, Life Technologies, Carlsbad, CA, USA) at a final concentration of 5 
µM in embryo media for 30 min in the dark prior to harvesting in 4% paraformaldehyde 
at 26 hpf.(Mugoni et al., 2014) The embryos were cryoprotected in successive sucrose 
solutions, embedded in O.C.T., and sectioned at 10 µm. The sections were immediately 
co-stained with DAPI and imaged as described above.  
 
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) 
 Total mRNA from 48 hpf embryos was isolated using the ReliaPrep RNA Tissue 
Miniprep System (Promega, Madison, WI, USA) and quantified using Nanodrop 2000 
(Thermo Scientific, Willmington, DE, USA) spectrophotometry. One microgram of RNA 
was reverse transcribed using Superscript IV Reverse Transcriptase (ThermoFisher 
Scientific, Waltham, MA, USA). The primer sequences for sod1, sod2, sod3, pitx2a, 
foxc1a, foxc1b, and β−actin are listed in Supplemental Table 1. For semi-quantitative 
RT-PCR, cycle optimization was performed to determine the linear range of each primer 
set (Supplemental Table 1). PCR was performed using Platinum Taq (ThermoFisher), 
and the products were detected on 2% agarose gels. Each experiment was repeated 4 
times, and the images shown are representative of all experiments. 
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In situ hybridization 
In situ hybridization was performed through standard protocols using digoxigenin- 
labeled RNA antisense probes (Barthel and Raymond, 2000;Bohnsack et al., 2011b). 
For colorimetric reactions, the embryos were developed for equal amounts of time. 
Sense controls were also developed in parallel to ensure specific staining.  
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RESULTS 
Migration of craniofacial and periocular neural crest showed different sensitivities 
to ETOH.  
Traceable differences between the cranial neural crest cells that give rise to the 
craniofacial structures versus those that contribute to the anterior segment of the eye 
were determined using the Tg(sox10:mRFP), Tg(foxd3:GFP) and Tg(sox10:mRFP; 
foxd3:GFP) transgenic lines. The transcription factors sox10 and foxd3 have been 
shown in numerous animal models to regulate early neural crest differentiation and are 
markers for neural crest cells (Dutton et al., 2001b;Honoré et al., 2003;Kwak et al., 
2013;Montero-Balaguer et al., 2006;Stewart et al., 2006). In the present study, we 
observed that sox10 and foxd3 predominantly demarcated separate neural crest cell 
populations in the periocular mesenchyme and within the eye (Fig. 1 A’’-D’’). Only a 
small proportion of neural crest cells entering the eye were sox10-positive (Fig. 1A-D). 
These sox10-positive cells migrated between the optic cup and surface ectoderm, 
peaking at approximately 36 hpf. Sox10 was no longer detected in the anterior segment 
after 60 hpf (Fig. 1D, 1D’’, and 1F), but maintained expression in the jaw and 
pharyngeal arches at 96 hpf (Fig. 1E, F). As previously demonstrated, foxd3 marked a 
higher proportion of neural crest cells that entered the eye (Fig. 1A’-D’) (Williams et al., 
2017). Foxd3-positive cells migrated between the optic cup and surface ectoderm and 
(arrow, Fig. 1B’, 1C’, 1B’’ and 1C’’) and through the ocular fissure (arrow). Foxd3-
positive cells coalesced around the lens and contributed to the iris stroma (closed 
arrow, Fig. 1E, 1F’), corneal stroma (Fig. 1F’, open arrow), and aqueous outflow 
channels (Fig. 1F’, arrowhead) at 96 hpf. Foxd3 was not expressed in the jaw or 
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pharyngeal arches at 96 hpf (Fig. 1E’). Foxd3 was also detected in differentiated 
photoreceptors (Fig. 1E’ and 1F’, open arrowhead), but this expression was not related 
to neural crest cells. Thus, sox10 and foxd3 demarcated different neural crest cell 
populations that give rise to the jaw/pharyngeal arches and anterior segment structures, 
respectively. 
To determine the effect of ETOH on anterior segment formation, Tg(foxd3:GFP) 
embryos were treated with increasing concentrations of ETOH (0.5%, 1% and 3%) 
between 24 and 48 hpf and subsequently live imaged. This time frame occurs after 
early neural crest migration into the craniofacial region and optic cup formation and 
during neural crest migration into the anterior segment of the eye. Treatment with 0.5% 
or 1% ETOH between 24 and 48 hpf did not decrease embryo survival at 72 hpf 
compared to untreated embryos (Fig. 2A) or significantly affect eye size (Fig. 2B, 
Supplemental Table 2) as measured along the dorsal-ventral and anterior-posterior 
axes. In the eye, 0.5% (data not shown) or 1% ETOH (Fig. 3B’-3E’) did not decrease 
foxd3-positive cells in the periocular mesenchyme (arrowheads) or alter ocular neural 
crest migration (closed arrows) between 24 and 72 hpf compared to untreated controls 
(Fig. 3A-E). Further, 1% ETOH did not affect photoreceptor expression of foxd3 at 72 
hpf (open arrows, Fig. 1E’). At 96 hpf, methylacrylate sections showed that 1% ETOH 
did not affect iris stroma formation (arrowheads, Fig. 3F’) compared to untreated 
embryos (Fig. 3F). In contrast, treatment of Tg(sox10:EGFP) embryos with 1% ETOH 
from 24 to 48 hpf (Fig. 3G’) showed delayed development of the pharyngeal arches 
(PA), ceratohyal (CH) cartilage, and Meckel’s (Mk) cartilage at 96 hpf compared to 
untreated controls (Fig. 3G).  
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Treatment with 3% ETOH from 24 to 48 hpf significantly decreased eye size in 
both the dorsal-ventral and anterior-posterior axes (Fig. 2B, Supplemental Table 2). 
However, 3% ETOH from 24 to 48 hpf did not significantly decrease embryo survival at 
72 hpf (p=0.81). In Tg(foxd3:GFP) embryos this higher concentration of ETOH 
significantly decreased the number of foxd3-positive neural crest cells in the periocular 
mesenchyme (arrowheads) and in the developing eye (arrows) at 48 hpf compared to 
untreated and 1% ETOH treated embryos (Supplemental Table 3, Fig. 3B’’-E’’, 3H,). However, 
there were foxd3-positive cells that migrated into the anterior segment (arrow) between 
36 and 72 hpf. Although the eyes were smaller with misshapen lenses, the neural crest 
cells formed iris stroma (arrowheads, Fig. 3F’’) and corneal stroma (arrow) at 96 hpf. 
Treatment of Tg(sox10:EGFP) embryos with 3% ETOH resulted in severe malformation 
of pharyngeal arch, ceratohyal, and Meckel’s cartilage at 96 hpf (Fig. 3G””). Thus, 
periocular and ocular neural crest cells are less sensitive to ETOH compared to the 
neural crest cell population that gives rise to the craniofacial cartilages.  
 
Ethanol induced apoptosis in the retina, lens, and facial mesenchyme. 
 Previous studies have shown that ETOH increases craniofacial neural crest 
apoptosis, but the effects of ETOH on the survival of the neural crest inside and around 
the eye have not been determined (Garic-Stankovic et al., 2005;Smith et al., 2014). 
TUNEL assay in Tg(sox10:EGFP) and Tg(foxd3:GFP) embryos demonstrated that 1% 
ETOH starting at 24 hpf significantly increased the percentage of apoptotic cells in the 
developing eye at 30 (Fig. 4C’ and 4D’) and 33 (Fig. 4E’ and 4F’, Fig. 5, Supplemental 
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Table 4) hpf compared to untreated controls (Fig. 4C-4F). The apoptotic cells in the 
eyes were not specifically localized to sox10 or foxd3-positive neural crest cells in the 
periocular mesenchyme or the eye. Treatment with 1% ETOH did not affect cell survival 
at 27 (Fig. 4A’ and 4B’), 36 (Fig. 4G’ and 4H’) and 48 (Fig. 4I’ and 4J’) hpf compared to 
untreated controls (Fig. 4E-4J). Between 30 and 48 hpf, apoptotic cells were also 
observed in the jaw mesenchyme (arrowheads, Fig. 4F’, 4H’ and 4I’). Treatment with 
3% ETOH starting at 24 hpf significantly increased the percentage of apoptotic cells in 
the developing eye from 30 to 48 hpf (Fig. 4C’’-4J’’, Fig. 5, Supplemental Table 4). In 
3% ETOH-treated embryos, the cells undergoing apoptosis were located throughout the 
eye, particularly in the retina and lens (Fig. 4C’’ and 4D’’). These findings show that 
ETOH induced apoptosis in the neural crest in the facial mesenchyme, but spared the 
neural crest in the anterior segment of the eye.  
 
Ethanol increased oxidative stress in the facial mesenchyme, but not the ocular 
neural crest.   
 Ethanol-induced apoptosis in the cranial neural crest and neuroepithelium has 
previously been attributed in part to an increase in oxidative stress (Chen et al., 
2000;Davis et al., 1990;Floyd and Carney, 1992;Henderson et al., 1995). Using Tg 
(sox10:mRFP) embryos, we investigated whether ETOH exposure increased ROS in 
and around the eye. Within 2 hours of ETOH exposure (1% or 3%), increased ROS was 
observed in the sox10-positive ventral neural crest cells, which forms the facial 
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mesenchyme (arrows, Fig. 6B and 6C), compared to untreated controls (Fig. 6A). 
However, there was no increased ROS within the developing eye. 
 Superoxide dismutase enzymes, namely sod1, sod2, and sod3, are important 
antioxidant molecules that catalyze the conversion of ROS to less harmful byproducts 
(Kajimura et al., 2005;Koch et al., 1994;Koch et al., 1991;Koch et al., 2004). To 
investigate the resistance of periocular and ocular neural crest cells to oxidative stress-
induced by ETOH, the expression of the sod genes in and around the developing eye 
was next determined. In situ hybridization at 36 hpf showed that all of the sod enzymes 
were expressed within the hyaloid vasculature (arrowhead, Fig. 6D-6F) and periocular 
mesenchyme. Sod1 and sod3 were also expressed within the retina and facial 
mesenchyme (open arrow), while sod2 was the predominant enzyme in the anterior 
segment. Sod2 was expressed in lens epithelial cells and the neural crest cells between 
the optic cup and surface ectoderm (arrows, Fig. 6E’,). Semi-quantitative RT-PCR of 
RNA from whole 48 hpf embryos revealed that treatment with 1% or 3% ETOH starting 
at 24 hpf decreased the overall transcript expression of sod1 and sod3 compared to 
untreated controls (Fig. 6G). Notably, 1% ETOH increased sod2 expression at 48 hpf, 
whereas treatment with 3% ETOH decreased sod2 expression. Immunohistochemistry 
confirmed protein expression of Sod2 within the anterior segment (arrows, Fig. 6H) and 
further showed that protein levels were increased by 1% ETOH (Fig. 6H’), but 
decreased by 3% ETOH exposure (Fig. 6H’’). Thus, the developing eye has regional 
expression of sod enzymes that are differentially regulated by ETOH exposure.  
 Since Sod2 was expressed in the anterior segment, the effect of this enzyme on 
the ocular neural crest was determined. Knockdown of Sod2 (using MO injected into 1-
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cell stage Tg(foxd3:GFP) embryos) did not affect foxd3-positive cell migration into the 
anterior segment between 36 and 72 hpf (closed arrows, Fig. 7E-7H) compared to 
mismatch control-injected (Fig. 7A-7D) and uninjected (Fig. 3B-3E) embryos. 
Immunohistochemistry (Fig. 6I) confirmed that MO injection decreased Sod2 protein 
expression at 48 hpf in whole embryos and within the anterior segment. In the setting of 
Sod2 MO knockdown, treatment with 1% ETOH from 24 to 48 hpf decreased foxd3-
positive neural crest cell migration into the anterior segment (arrows, Fig. 7E’-7H’). 
However, there were still foxd3-positive cells in the periocular mesenchyme 
(arrowheads). This was in contrast to mismatch control-injected (Fig. 7A’-7D’) or 
uninjected (Fig. 3B’-3E’) embryos in which 1% ETOH did not affect foxd3-positive cell 
migration into the anterior segment. Treatment with 3% ETOH between 24 and 48 hpf 
decreased foxd3-positive cells in the periocular mesenchyme (arrowheads) and in the 
developing eye in Sod2 knockdown (Fig. 7E’’-7H’’), mismatch control-injected (Fig. 7A’’-
D’’), and uninjected (Fig. 3B’’-3E’’) embryos. These results show that Sod2 provides a 
protective effect against low levels of ETOH exposure in the developing eye.  
 
Ethanol had a minimal effect on the expression of periocular and ocular genes 
associated with congenital eye diseases.  
 Malformations of the cornea, iris, and angle structures are associated with 
mutations in PITX2 and FOXC1 (Ozeki et al., 1999;Strungaru et al., 2007;Tumer and 
Bach-Holm, 2009). Thus, we next investigated the effect of ETOH exposure on the 
expression of these genes in the periocular mesenchyme and developing eye. Although 
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pitx2 has multiple isoforms in zebrafish, we previously demonstrated that pitx2a is the 
predominant form responsible for eye development (Bohnsack et al., 2012). There are 2 
isoforms of foxc1 in zebrafish, foxc1a and foxc1b (Skarie and Link, 2009). Semi-
quantitative RT-PCR showed that 1% or 3% ETOH did not affect the overall expression 
of pitx2a or foxc1a in RNA isolated from whole 48 hpf embryos (Fig. 7A). In situ 
hybridization, which was used to assess expression pattern in the craniofacial region, 
showed that 1% or 3% ETOH starting at 24 hpf did not significantly alter pitx2a 
expression in the pituitary (yellow arrow, Fig. 7B, 7B’, 7B’’) or in the ocular fissure (open 
arrow, Fig. 7B, 7B’, and 7B’’). In addition, ETOH did not significantly affect the 
expression pattern of foxc1a in the periocular mesenchyme (yellow arrow, Fig. 7C, 7C’, 
and 7C’’) and within the ocular fissure (open arrow, Fig. 7C, 7C’, and 7C’’). However, 
treatment with 3% ETOH decreased the overall expression of foxc1b in 48 hpf embryos 
(Fig. 7A), including in the periocular mesenchyme (open arrow, Fig. 7D, D’, and D’’) and 
facial mesenchyme (closed arrows, Fig. 7D, D’, and D’’). These findings show that 
ETOH affected foxc1b, but not foxc1a or pitx2a in the periocular mesenchyme and 
developing eye.  
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DISCUSSION 
FAS disorders reflect the disruption of developmental events as a result of 
prenatal alcohol exposure. The major findings and diagnostic criteria include prenatal 
and postnatal growth delay, craniofacial anomalies, and central nervous system 
manifestations (Hoyme et al., 2005;Lemoine et al., 2003;Riley et al., 2011;Sokol, 2003). 
The eyes and visual system, as an extension of the central nervous system, are often 
affected (Brennan and Giles, 2014;Chan et al., 1991;Gummel and Ygge, 2013;Ribeiro 
et al., 2007;Stromland, 1987;Stromland and Pinazo-Duran, 2002;Stromland et al., 
2015). The most common intraocular finding is optic nerve hypoplasia, which affects up 
to 50% of children with FAS and can result in significant visual impairment 
(Abdelrahman and Conn, 2009;Brennan and Giles, 2014;Gummel and Ygge, 
2013;Ribeiro et al., 2007;Stromland and Pinazo-Duran, 2002;Stromland et al., 2015). 
Microphthalmia (small disorganized globe) is also listed as part of the diagnostic criteria 
for FAS (Rossett, 1980), however the prevalence of this condition is more rare (0-5%) in 
children with FAS (Abdelrahman and Conn, 2009;Brennan and Giles, 2014;Gummel 
and Ygge, 2013;Ribeiro et al., 2007;Stromland and Pinazo-Duran, 2002;Stromland et 
al., 2015). Both optic nerve hypoplasia and microphthalmia reflect disruptions in 
neuroepithelial-derived optic vesicle formation. Although the neural crest, which gives 
rise to the cornea, iris, sclera, and angle structures, can be disrupted in the context of 
microphthalmia, only 9 cases of isolated anterior segment anomalies in the setting of 
FAS have been reported (Edward et al., 1993;Miller et al., 1984). In contrast, genetic 
causes of congenital anomalies often affect both craniofacial structures and anterior 
segment development (Aliferis et al., 2010;Dressler et al., 2010;Ozeki et al., 1999). 
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Hence, although craniofacial abnormalities are commonly observed in FAS, the 
development of the anterior segment of the eye is rarely affected, indicating that ocular 
neural crest cells are less sensitive to the effects of ETOH than their craniofacial 
counterparts. 
Cellular and molecular differences between the cranial neural crest cells that give 
rise to craniofacial structures versus those that generate anterior segment structures 
have not been well defined. Although the molecular characteristics and migratory 
pathways of the neural crest cells that give rise to the frontonasal process, Meckel’s 
cartilage, ceratohyal cartilage and pharyngeal arches have been well studied, less is 
known about the cells destined for the anterior segment of the eye. Both of these cell 
populations originate from the edge of the neural tube and migrate into the craniofacial 
region (Dougherty et al., 2012;Trainor, 2005). Our previous studies have shown that 
cells destin d for the anterior segment migrate dorsal and ventral to the eye and 
populate the periocular mesenchyme (Bohnsack and Kahana, 2013;Chawla et al., 
2016). However, specific markers for the cells that enter into the eye have not been 
previously identified. In the present study, we observed that sox10 expression was 
decreased in the periocular mesenchyme, and few sox10-positive cells entered the eye 
between the surface ectoderm and optic cup. Further, foxd3 marked a large population 
of cells entering the anterior segment. Although the majority of these cells migrated into 
the dorsal-posterior quadrant between the surface ectoderm and optic cup, foxd3-
positive cells also migrated through the ocular fissure, entering into the anterior 
segment. Studies in mice, chickens, and humans have not demonstrated this alternative 
pathway, however, these studies did not utilize time-lapse live imaging of this migratory 
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cell population. In zebrafish, similar to mice, we did not observe distinct waves of neural 
crest cells as previously described in humans and chickens (Hay and Revel, 
1969;O'Rahilly, 1966;1975;Pei and Rhodin, 1970). Classic anatomy studies have 
described 3 waves of neural crest cells in humans and 2 waves in chickens. In humans, 
the first wave contributes to the cornea, the second wave gives rise to the iris, and the 
third wave forms the angle structures. While fate mapping has confirmed that these 
anterior segment structures are derived from the neural crest in chickens and mice, 
similar studies have not been conducted in zebrafish (Gage et al., 2005;Johnston et al., 
1979;Noden, 1983). In the present study, we observed foxd3-positive cells in the iris 
stroma, corneal stroma, and aqueous outflow system in the larval eye, but foxd3 was no 
longer expressed in the adult anterior segment. Additional studies are required to 
determine the ultimate fate of these cells in the adult eye. Thus, foxd3 is a marker that 
demarcates the ocular population of cranial neural crest cells. These studies were 
necessary for determining differences in ETOH sensitivity between the craniofacial and 
ocular neural crest populations.  
The majority of animal studies focusing on ETOH and ocular development 
highlight the teratogenic effects on the neuroepithelial-derived optic nerve and retina. 
These previous studies have recapitulated optic nerve hypoplasia and microphthalmia 
in different animal models, but have not determined the effect of ETOH on the neural 
crest cells that contribute to the anterior segment (Cook et al., 1987;Phillips et al., 
1991;Pinazo-Duran et al., 1993;Stromland and Pinazo-Duran, 2002). In the present 
study, we observed that the survival and migration of foxd3-positive neural crest cells in 
the eye were less sensitive to ETOH compared with their sox10-positive counterparts 
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destined for craniofacial structures. This difference may in part reflect the increased 
resistance of periocular and ocular neural crest cells to ROS generation in response to 
ETOH exposure. Numerous studies have linked the cellular effects of alcohol to 
increased oxidative stress in both adult and embryonic tissues (Chu et al., 2007;Heaton 
et al., 2002;Henderson et al., 1995;Koch et al., 1991;Koch et al., 2004;Videla et al., 
1983). The cranial neural crest and developing brain have relatively low levels of 
antioxidant enzymes compared to the liver or kidneys, making these tissues more 
susceptible to free radical damage (Chen et al., 2000;Davis et al., 1990;Floyd and 
Carney, 1992). Indeed, supplementation with antioxidants has been shown to decrease 
the craniofacial and neurological phenotypes in animal models of FAS (Heaton et al., 
2000;Joya et al., 2015;Wentzel and Eriksson, 2006). Ethanol predominantly increases 
oxidative stress within mitochondria, and as a result, there is a compensatory increase 
in the expr ssion of the mitochondrial form of superoxide dismutase (sod2) in adult 
tissues (Koch et al., 1994;Koch et al., 2000). Similarly, rat cranial neural crest cells 
exposed to ETOH show an increase in Sod2, but not the soluble (Sod1) or extracellular 
(Sod3) forms (Chen and Sulik, 1996;Wentzel and Eriksson, 2006). The results of the 
present study further revealed that low levels of ETOH, which did not disrupt neural 
crest migration into the eye, increased the expression of the antioxidant enzyme, sod2. 
Interestingly, this enzyme was highly expressed in the developing anterior segment and 
knockdown of Sod2 resulted in increased sensitivity of the ocular neural crest to these 
low levels of ETOH. In contrast, ETOH decreased the expression of sod1 and sod3, 
which were expressed in the retina and facial mesenchyme. This suggests a model in 
which Sod2 has a protective effect against oxidative stress in the developing anterior 
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segment and this may account for the decreased sensitivity of the ocular neural crest to 
ETOH exposure compared to craniofacial neural crest.  
 The migration, proliferation and differentiation of neural crest cells that enter into 
the eye are also regulated through interactions with the optic cup. Retinoic acid is a key 
regulator that mediates signaling between the developing retina and periocular neural 
crest. In mice, chickens and zebrafish, retinoic acid is produced in the developing dorsal 
and ventral retina (Bohnsack et al., 2012;Molotkov et al., 2006;Suzuki et al., 2000). The 
retinoic acid receptors (RAR) α, β, and γ are expressed in the periocular mesenchyme, 
and retinoic acid signaling regulates neural crest cell survival and migration via the 
expression of Pitx2 and Foxc1 (Bohnsack et al., 2012;Dupe et al., 1999;Kumar and 
Duester, 2010;Matt et al., 2005;Matt et al., 2008). Further, tight control of retinoic acid 
levels is required for proper formation of the iris stroma and cornea in the anterior 
segment (Bohnsack et al., 2012). Retinoic acid is hypothesized to be a putative target of 
ethanol through the competitive inhibition of the retinoic acid synthesis enzyme, retinol 
dehydrogenase (Deltour et al., 1996). In zebrafish, retinoic acid together with sonic 
hedgehog can rescue certain phenotypes associated with ethanol exposure, including 
brain abnormalities, microphthalmia, and retinal differentiation (Muralidharan et al., 
2015;Zhang et al., 2016). However, these FAS phenotypes result from neuroepithelial 
cell anomalies and not neural crest defects. Less is known about the effects of ethanol 
on retinoic acid in the neural crest, particularly neural crest cell populations in the 
periocular mesenchyme and developing eye. However, in the present study expression 
of pitx2a and foxc1a, which are known targets of retinoic acid, was minimally affected by 
ETOH exposure suggesting that ETOH may not regulate retinoic acid signaling in the 
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periocular mesenchyme.  Prior studies have shown that pitx2 and foxc1 are critical for 
neural crest migration and anterior segment formation (Berry et al., 2008;Bohnsack et 
al., 2012;Chawla et al., 2016;Evans and Gage, 2005;Gage et al., 1999;Kume et al., 
2000;Skarie and Link, 2009). Clinically, gain- or loss-of-function mutations of either of 
these genes are most commonly associated with Axenfeld-Rieger syndrome, an 
autosomal dominant congenital disease characterized by anterior segment dysgenesis 
and craniofacial abnormalities (Leis et al., 2012;Strungaru et al., 2007;Tumer and Bach-
Holm, 2009). Taken together, these studies further demonstrated that the neural crest 
cells around and within the developing eye are more robust to the effects of ETOH and 
maintain the molecular signals required for anterior segment formation.  
 The present study assessed the cellular and molecular effects of ETOH on the 
neural crest cells that form the anterior segment of the eye. Consistent with the rarity of 
anterior segment abnormalities associated with FAS, the neural crest cell populations in 
the periocular mesenchyme and within the developing eye were less sensitive to ETOH 
exposure compared to the neural crest that gives rise to the jaw and pharyngeal arches. 
These studies provide further insight into the pathogenesis of congenital anomalies and 
the effects of prenatal alcohol exposure on craniofacial and ocular development. 
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FIGURE LEGENDS 
Fig. 1. Sox10 and foxd3 demarcated temporally and spatially distinct neural crest 
cells. Live imaging and lateral section immunofluorescence (IF) of 24 to 60 hpf 
Tg(sox10:mRFP), Tg(foxd3:GFP) and Tg(sox10:mRFP; foxd3:GFP) embryos showed 
the expression and migration patterns of sox10 and foxd3-positive cells in the periocular 
mesenchyme and developing anterior segment. Sox10 was highly expressed in the 
periocular mesenchyme at 24 hpf (A, A’’), but showed decreased expression by 60 hpf 
(B-D, B’’-D’’). A small proportion of sox10-positive cells migrated into the eye between 
the surface ectoderm and optic cup from 24 to 48 hpf (A-C, A’’-C’’). Few sox10-positive 
cells were observed in the anterior segment at 60 hpf (D). Ventral live imaging (E) and 
coronal IF sections (F) showed sox10-positive cells in the craniofacial structures 
(pharyngeal arches (PA), ceratohyal cartilage (Ch), and Meckel’s cartilage (Mk)), but not 
in the developing anterior segment, at 96 hpf. Foxd3-positive cells predominantly 
migrated into the anterior segment in the dorsal (d)–posterior (p) quadrant between the 
surface ectoderm and optic cup from 30 to 60 hpf (A’-D’). In addition, foxd3-positive 
cells migrated through the ocular fissure between 30 and 48 hpf (arrows, B’, B’’, C’, C’’). 
At 96 hpf, foxd3 expression (E’, F’) was localized to the iris stroma (closed arrow), 
cornea (open arrow), and aqueous outflow tracts (closed arrow head), but was not 
expressed in the pharyngeal arches, Meckel’s cartilage or ceratohyal cartilage. Foxd3 
was expressed in retinal photoreceptors (open arrowhead, E’, F’) at 96 hpf, but this 
expression was not related to neural crest cells. Section analysis showed little overlap in 
expression of sox10 and foxd3 in neural crest cells entering the anterior segment (A’’-
D’’). a, anterior; d, dorsal; p, posterior; v, ventral. 
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Fig. 2. ETOH treatment from 24 to 48 hpf did not significantly affect embryonic 
survival, but did inhibit eye size. Treatment with 0.5%, 1% or 3% ETOH from 24 to 48 
hpf did not significantly increase the percentage of embryo death assessed at 72 hpf 
(A). Treatment with 0.5% or 1% ETOH did not significantly affect the length (in µm) of 
the eye in either the dorsal-ventral or anterior-posterior axis (B). However, treatment 
with 3% ETOH significantly decreased the eye size in both the dorsal-ventral and 
anterior-posterior axes compared to untreated embryos (B). *, p<0.05. 
 
Fig. 3. Craniofacial neural crest cells were more sensitive to ETOH than periocular 
and ocular neural crest cells. Live imaging of Tg(foxd3:GFP) embryos from 24 (A) to 
72 hpf demonstrated that treatment with 1% ETOH from 24 to 48 hpf (B’-E’) did not alter 
the migration of foxd3-positive cells between the surface ectoderm and optic cup 
(closed arrows) or through the ocular fissure compared to untreated controls (B-E). In 
addition, 1% ETOH did not affect the number of foxd3-positive cells in the periocular 
mesenchyme (closed arrowheads in B’-D’, H). Methylacrylate sections of 96 hpf 
embryos showed that 1% ETOH treatment from 24-48 hpf did not affect iris stroma 
cellularity (arrowheads, F’) compared to untreated embryos (F). In contrast, live imaging 
of Tg(sox10:EGFP) embryos at 96 hpf showed that treatment with 1% ETOH from 24 to 
48 hpf (G’) delayed Meckel’s (Mk) cartilage, ceratohyal (CH), and pharyngeal arch (PA) 
cartilage formation compared to untreated controls (G). Treatment with 3% ETOH from 
24 to 48 hpf caused developmental delay by 36 hpf (B’’) and at 48 hpf significantly 
decreased the number of foxd3-positive cells present in the periocular mesenchyme 
(closed arrowhead in C’’, H). Further, there were fewer foxd3-positive cells in the 
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developing eye (closed arrows, B’’-E’’) of 36 to 72 hpf embryos treated with 3% ETOH. 
However, analysis of methylacrylate sections at 96 hpf (F’’) showed that neural crest 
cells were present in the iris stroma (closed arrowheads) and corneal stroma (arrows), 
though the corneas were thickened and the lenses were misshapen. Treatment with 3% 
ETOH inhibited sox10-positive neural crest cell-derived pharyngeal arch formation and 
resulted in ceratohyal and Meckel’s cartilage malformation (G’’).  
 
Fig. 4. ETOH increased apoptosis in craniofacial neural crest cells but not ocular 
neural crest cells. TUNEL assay on sections from 27 to 48 hpf Tg(sox10:EGFP) or 
Tg(foxd3:GFP) embryos demonstrated that treatment with 1% ETOH starting at 24 hpf 
caused a transient increase in apoptosis within the eye at 30 (C’, D’) and 33 (E’, F’) hpf 
compared to untreated embryos (C-F). The apoptosis was not localized to either sox10-
positive or foxd3-positive cells within the eye. In contrast, 1% ETOH did not affect cell 
survival in the developing eye at 27 (A’, B’), 36 (G’, H’), or 48 (I’, J’) hpf. Treatment with 
3% ETOH starting at 24 hpf caused a significant decrease in cell survival within the eye 
(A’’-H’’), but this apoptosis was not specifically localized to sox10- or foxd3-positive cells 
in the ocular neural crest. In contrast, 1% or 3% ETOH increased apoptosis in sox10-
positive cells (closed arrowhead, E’’, I’) in the facial mesenchyme (closed arrowhead, F’ 
and H’). 
 
Fig. 5. ETOH significantly increased apoptosis within the developing eye. 
Treatment with 1% ETOH from 24 to 48 hpf showed a transient increase in the 
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percentage of apoptotic cells within the developing eye at 30 and 33 hpf. Treatment with 
3% ETOH significantly increased the percentage of apoptotic cells in the eye after 6 
hours, and this effect continued through 48 hpf.  
 
Fig. 6. Ethanol increased oxidative stress in the facial mesenchyme, but not in the 
anterior segment. Tg(sox10:mRFP) embryos showed that 1% or 3% ETOH treatment 
starting at 24 hpf increased ROS in sox10-positive cells in the facial mesenchyme 
(arrows, B, C) within 2 hours of treatment compared to untreated controls (A). In situ 
hybridization of 36 hpf embryos demonstrated that sod1 (D, D’) and sod3 (F, F’) were 
expressed in the hyaloid vasculature (arrowhead) and retina in the eye, the periocular 
mesenchyme, and the facial mesenchyme (open arrow). Sod2 was also expressed in 
the periocular mesenchyme and hyaloid vasculature (arrowhead, E). In addition, sod2 
was expressed in the anterior segment of the eye (E’) in lens epithelial cells and neural 
crest cells between the optic cup and surface ectoderm (arrow). Semi-quantitative RT-
PCR (G) of RNA derived from whole 48 hpf embryos showed that 1% ETOH starting at 
24 hpf decreased the expression of sod1 and sod3, but increased the expression of 
sod2. Treatment with 3% ETOH from 24 to 48 hpf decreased the expression of sod1, 
sod2, and sod3. Immunohistochemistry confirmed the expression of Sod2 protein in the 
anterior segment (arrows, I). Sod2 protein expression was increased by 1% ETOH (I’), 
but decreased by 3% ETOH (I’’). Knockdown of Sod2 by MO injection showed 
decreased protein expression in untreated (J), 1% ETOH-treated (J’), and 3% ETOH-
treated (J’’) embryos.  
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Fig. 7. Sod2 decreases effects of ETOH on ocular neural crest and anterior 
segment development. Live imaging of Tg(foxd3:GFP) embryos showed that foxd3-
positive cell migration into the anterior segment between 36 and 72 hpf was not affected 
by Sod2 MO knockdown (arrows, Fig. 7E-7H) compared to mismatch control-injected 
(Fig. 7A-7D) embryos. Knockdown of Sod2 in combination with 1% ETOH treatment 
from 24 to 48 hpf decreased foxd3-positive neural crest cell migration into the anterior 
segment (arrows, Fig. 7E’-7H’), but did not affect the cells in the periocular 
mesenchyme (arrowheads). This was in contrast to mismatch control-injected (Fig. 7A’-
7D’) embryos in which 1% ETOH did not affect foxd3-positive cells in the periocular 
mesenchyme (arrowheads) or in the anterior segment migration (arrows). Treatment 
with 3% ETOH between 24 and 48 hpf decreased foxd3-positive cells in the periocular 
mesenchyme and in the developing eye in Sod2 knockdown (Fig. 7E’’-7H’’) and 
mismatch control-injected (Fig. 7A’’-D’’) embryos.  
 
Fig. 8. Ethanol had a minimal effect on the expression of periocular and ocular 
genes associated with congenital eye diseases. Semi-quantitative RT-PCR showed 
that 1% or 3% ETOH treatment from 24 to 48 hpf had minimal effect on expression of 
pitx2a, and foxc1a in RNA isolated from whole 48 hpf embryos. Foxc1b expression was 
decreased after treatment with 3% ETOH, but not 1% ETOH. Whole mount in situ 
hybridization in untreated (B), 1% ETOH treated (B’), and 3% ETOH treated (B’’) 48 hpf 
embryos demonstrated that pitx2a was expressed in the pituitary (yellow arrows), 
periocular mesenchyme, and the ocular fissure (open arrows). Foxc1a was expressed 
in the facial mesenchyme, periocular mesenchyme (yellow arrows), and in the ocular 
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fissure (open arrows) of untreated (C), 1% ETOH treated (C’), and 3% ETOH treated 
(C’’) 48 hpf embryos. Similar to foxc1a, foxc1b was expressed in the facial mesenchyme 
(black arrows) and periocular mesenchyme (open arrows), but not in the ocular fissure 
of untreated (D) and 1% ETOH treated (D’) 48 hpf embryos. Treatment with 3% ETOH 
decreased foxc1b expression (D’’) in the facial mesenchyme and periocular 
mesenchyme. 
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